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Abstract 
The European Food Safety Authority (EFSA) carried out a public consultation to receive input from 
interested parties on a draft scientific opinion on the risks for animal and human health related to 
the presence of glycoalkaloids in feed and food, in particular in potatoes and potato-derived products. 
This draft scientific opinion was prepared by the EFSA Panel on Contaminants in the Food Chain 
(CONTAM Panel), supported by the Working Group on Glycoalkaloids in feed and food. The draft 
opinion was endorsed by the CONTAM Panel for public consultation by written procedure on 
19 February 2020. The written public consultation was open from 27 February 2020 until 15 April 
2020. EFSA received comments from nine different interested parties. EFSA and its CONTAM Panel 
wish to thank all stakeholders for their contributions. The present report contains the comments 
received and explains the way they have been considered for finalisation of the opinion. The opinion 
was adopted at the CONTAM Plenary meeting on 7 July 2020 and published in the EFSA Journal.  
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1. Introduction  
1.1. Background and Terms of Reference as provided by the requestor 
1.1.1. Background 
Many plants in the family Solanaceae contain glycoalkaloids, and they are considered to be natural 
toxins. The plant glycoalkaloids are toxic steroidal glycosides and the commonest types found in food 
plants are -solanine and -chaconine. Their natural function is probably to serve as stress metabolites 
or phytoalexins for the protection of the plant when attacked by insects, fungi, etc. 
Amongst the most widely cultivated food crops, aubergines, tomatoes and potatoes are in the 
Solanaceae family, but the levels of glycoalkaloids in tomatoes and aubergines are generally quite low. 
The glycoalkaloids of most relevance to food safety are those occurring in the potato. The predominant 
toxic steroidal glycosides in potato are -solanine and -chaconine. They occur in potato tubers, peel, 
sprouts, berries, leaves and blossoms and their concentration in tubers depends on a number of factors, 
such as cultivar, maturity and environmental factors. Concentrations of glycoalkaloids are 3 to 10 times 
greater in the peel than in the flesh. There is considerable variation in glycoalkaloid content among 
potato cultivars. Storage conditions, especially light and temperature, are mainly responsible for 
increases in solanine. Although the glycoalkaloid content can increase in the dark, the rate of formation 
is only about 20% the rate of formation in light. Increases of solanine in the potato peel are closely 
associated with greening (synthesis of chlorophyll) of the peel. These biochemical processes are 
independent of each other but are both activated by light.  
Bitter or burning sensation in the mouth are sensory impressions which may accompany glycoalkaloid 
poisoning symptoms from potatoes that include flu-like symptoms such as nausea, vomiting, stomach 
and abdominal cramps, and diarrhoea. More severe cases of glycoalkaloid poisoning may be 
accompanied by a variety of neurological effects (i.e. drowsiness, apathy, restlessness, shaking, 
confusion, weakness, and disturbed vision). There are a few reports of deaths being attributed to 
glycoalkaloid exposure from the consumption of potatoes, potato leaves, and potato berries. 
Potatoes and potato-derived products are listed in the Catalogue of feed materials1. 
1.1.2. Terms of reference 
In accordance with Art. 29 (1) of Regulation (EC) No 178/2002, the European Commission asks the 
European Food Safety Authority for a scientific opinion on the risks for animal and human health related 
to the presence of glycoalkaloids in feed and food, in particular in potatoes and potato-derived products. 
1.2. Rationale for the public consultation and brief summary of its 
outcome 
In line with EFSA’s policy on openness and transparency, and in order for EFSA to receive comments on 
its work from the scientific community and stakeholders, EFSA engages in public consultations on key 
issues. Accordingly, the draft opinion together with its annex was released for public consultation from 
27 February 2020 to 15 April 2020 by means of an electronical comment submission tool together with 
explanatory text on the EFSA website (See Appendix A). Comments were received from nine interested 
parties from five countries. Table 1 provides an overview on the interested parties that have submitted 
comments through the electronic submission or via email. 
  
                                                          
1 Commission Regulation (EU) No 6812013 of 16 January 2013 on the Catalogue of feed materials (OJ L 29, 30.1.2013, p. 1). 
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Table 1:  Overview on stakeholder comments received 
Stakeholder Category (a) Country 
Federal Public Service Health, Food Chain Safety 
and Environment 
National authority Belgium 
German Federal Institute for Risk Assessment (BfR) National authority Germany 
Norwegian Scientific Committee for Food and 
Environment, Panel on Contaminants 
National authority Norway 
Max Rubner-Institut University/public research institute Germany 
National Institute for Public Health and the 
Environment (RIVM) 
University/public research institute 
The 
Netherlands 
European Potato Processors' Association (EUPPA) Private sector  Belgium 
Starch Europe (STARCH EU) Private sector Belgium 
Antonella Garzelli Private capacity 
United 
Kingdom 
Matthew Walker   Private capacity 
United 
Kingdom 
(a): As specified by the commenter.  
2. Assessment of comments and use for finalisation of the opinion 
The comments received were duly evaluated by the EFSA WG on Glycoalkaloids in feed and food and 
the CONTAM Panel, and wherever appropriate taken into account for finalisation of the draft opinion. 
Table 2 provides a detailed list with all comments as received from interested parties together with EFSA 
responses and explanations how the comments were considered for finalisation of the draft opinion. 
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Table 2: Stakeholder comments and EFSA responses 
Stakeholder Comment 
number 











Line 3919 - It would be useful to obtain confirmation whether the 
occurrence data on unprocessed potatoes were indeed analyzed 
unpeeled (with the skin). Peeling can be a sample preparation method 
















Food processing/reduction factors: The use of processing/reduction 
factors to data on potatoes is indeed a source of uncertainty. 1) It is 
known that specific varieties are used for the production of specific 
processed products, hence some varieties are grown for the production 
of potato crisps, etcetera. 2) experimental reduction factors are not the 
same as what happens in industry.  
There is a need to use real occurrence data in commercial samples. In 
Belgium, a survey for the Federal Public Service Health, Food Chain 
Safety and Environment is ongoing showing that potato crisps in retail 
have levels higher than expected from the information in the draft EFSA 
opinion. 
Of course, occurrence data on potato crisps should be combined with 
consumption data for potato crisps. 
Out of the initial 651 samples only 7 samples 
were reported explicitly as peeled and were not 
included in the average. Further, 18 samples 
reporting ‘processed’ potatoes under the 
PRODTREAT variable were also excluded. After 
the cleaning (see Annex A2), 604 samples were 
included in the final dataset. Of these, 25 
samples were explicitly reported as unpeeled.  
440 samples were reported as unprocessed and 
8 were reported both as unpeeled and 
unprocessed. The data providers confirmed they 
were not able to retrieve additional information 
on the peeling. Samples reported as 
unprocessed were considered unpeeled, because 
peeling implicates a processing step. In the 
absence of information about peeling or 
processing it was assumed that the 131 
remaining samples were analysed unpeeled. 
 
The CONTAM Panel acknowledged the 
uncertainty linked to the use of processing 
factors due to the limited data on processed 
potato products submitted to EFSA (as described 
in Section 3.5.2 of the Opinion). EFSA welcomes 
the submission of occurrence data on GAs in 
potato and potato products as well as other food 
groups via the Continuous Call for Data 





















Entire Chapter 1.3.2.2 (Detection methods): The chapter gives a 
good overview of past and current methods for glycoalkaloid detection 
and quantification. However, many of the presented methods are not in 
use anymore, e.g. gravimetric, colorimetric and GC-FID/NPD methods. 
It should be clearly stated in this chapter that use of these methods is 
not recommended due to the analytical drawbacks (in particular lacking 
specificity) and the availability of better methods (LC-MS). 
This section provides a general overview of the 
methods that have been used in the past and 
present for the analysis of GAs. 
Recommendation of analytical methods for the 
analysis of GAs is outside the remit of EFSA. 
However, to stress the current state of the art, 
in the introduction of Section 1.3.2 of the 
Opinion, a sentence has now been added that 
states that these unspecific methods are no 
longer used for quantitative purposes. 
Furthermore, in the paragraph on GC-FID 
methods a sentence has now been added that 
nowadays LC-based methods have replaced GC-
based methods. 
 
The CONTAM Panel also found it appropriate to 
add a new sub-section under Section 1.3.2 to 
acknowledge the availability of GAs and their 
aglycons as analytical standards, of reference 
material and of proficiency testing schemes.  
3 1.3.3. Sources line 596, p.17: The species name (here: Solanum) should be written 
in italic letters as it is done in the rest of the opinion. 




line 603, p.17: The species name (here: Solanum) should be written 
in italic letters as it is done in the rest of the opinion. 




lines 1225/1226, page 34 (3.1.1.2.1): It is suggested to add “after 
oral exposure” in the heading of table 5. “Pharmacokinetic parameters 
(ranges) of α-solanine and α-chaconine in human volunteers after oral 
exposure (adapted from Mesinga et al., 2005).” 
Editorial suggestion implemented. 
 
6 3.1.2.1. Acute 
toxicity studies 
lines 1372 and 1377, page 37 (3.1.2.1.2): Although this 
information may be found in the tables, it is suggested to add the 
following information also in the text for an easier reading: 
Wilson et al. 1961: Which compound was applied and via which route? 
Baker et al. 1989: Which application route was used? 
The information has now been added to the text 
in the Opinion.  












lines 1429 to 1431, page 44 (3.1.2.2.1): It is suggested to move 
this paragraph to 3.1.2.2 and to mention also table 13 in the text as the 
content of this section is applicable not only for chapter 3.1.2.2.1 but 
also for chapter 3.1.2.2.2. Otherwise, it should be separately noted 
under 3.1.2.2.2 that all these studies investigated effects following oral 
exposure. 
 
line 1630, page 51; line 1640, page 54; line 1647, page 56 
(3.1.2.2): It is highly recommended to add the word “dose” to the 
header of tables 11, 12 and 13: “Repeated dose oral toxicity studies…”. 
The information has been shifted ahead of 
Section 3.1.2.2.1 and applies now to Section 











lines 1825 and 1826, page 63 (3.1.2.3.1.4 ): Although this 
information may be found in the tables, it is suggested to add the route 
of exposure also in the text for an easier reading. 
 
line 1834, page 64 (3.1.2.3.2): Although this information may be 
found in the tables, it is suggested to add the route of exposure also in 
the text for an easier reading. 
 
line 1903, page 74; line 1906, page 75 (3.1.2.3.2): It is highly 
recommended to add the word “toxicity” to the header of tables 16 and 
17: “Reproductive toxicity studies…”. 








Editorial suggestion implemented.  












entire chapter: It is noted that the studies described within this 
chapter did investigate the pharmacological potential (anti-inflammatory 
effects) rather than immunotoxicity. It appears that these studies may 
be excluded. Since it is already stated in the first sentence that no 
standard immunotoxicity studies are available and the described studies 
do not directly address this issue, at least the last sentence of the 
chapter “No indication of immunotoxicity was seen in these studies” 
should be replaced, e.g. by “The CONTAM Panel notes that the 
available studies are not appropriate to conclude on the immunotoxic 
potential of GAs”. 
 
line 1913, page 76: The word “mg” after 100 mg may be deleted. 
 
line 1918, page 76: It appears that the dose of 0 mg/kg bw was 
added here by mistake. Otherwise the described effect would have 
been observed also at the control group. 
The CONTAM Panel acknowledges this comment 
and the following sentence has been added to 
Section 3.1.2.4 of the Opinion: “The CONTAM 
Panel notes that there is not sufficient 
information to conclude on the immunotoxic 






Editorial suggestion implemented. 
 
The CONTAM Panel notes this was added by 
mistake and the 0 mg/kg dose has been deleted.   
10 3.1.2.7. 
Genotoxicity 
lines 1965 to 1966, page 77 (3.1.2.7.1) and lines 1983 to 1984, 
page 77 (3.1.2.7.2): The available studies on the genotoxic potential 
of GAs are not sufficient to finally conclude on the genotoxic potential 
of these compounds. Therefore, the conclusion of the panel in chapter 
3.1.2.7.1 and 3.1.2.7.2 “…from the limited number of studies available, 
there was no evidence for genotoxicity…” should be supplemented, e.g. 
by “However, the available data is not appropriate to finally conclude 
on the genotoxic potential of GAs.” Furthermore, such a statement 
should also be added at the appropriate position in the summary (e.g. 
line 118), in chapter 3.1.6 (e.g. line 2934 and 2988) and in the 
conclusion (e.g. line 4021). 
The CONTAM Panel acknowledges the comment 
and the following sentence has been added to 
the Opinion in the relevant sections: “However, 
there is not sufficient information to conclude on 





line 2014, page 82 (3.1.2.9.2): It appears that one “that” has to be 
deleted. 
The duplication has been deleted.  





line 2321 to 2325, page 91 (3.1.3.2.1): The first case report 
presented in this chapter appears of less relevance as the described 
symptoms most probably arise from the contamination with Datura 
mental containing scopolamine and atropine. It is suggested to delete 
this case. 
The CONTAM Panel agrees and the study has 
now been deleted from the Opinion.  








Chapter Comment(a) EFSA response 
13 3.1.4. Adverse 





line 2425, page 94: It is highly recommended to add the word “oral” 
to the header of table 21: “Acute oral toxicity…”. 
 
line 2430, page 95; line 2434, page 96; line 2439, page 97: It is 
highly recommended to add the word “dose” to the header of tables 22, 
23 and 24: “Repeated dose toxicity of…”. 
Editorial suggestion implemented. 
 
 
Editorial suggestion implemented.  
14 3.1.6.1. GAs 
from edible 
parts of S. 
tuberosum 
lines 2877 to 2878, page 108 (3.1.6.1.1): The last part of the 
clause “Based on human data on case reports, outbreaks and studies in 
volunteers, the CONTAM Panel selected the LOAEL of 1 mg potato 
TGA/kg bw per day as the reference point for acute exposure to potato 
TGAs via food” might be misleading to the reader. It is suggested to 
replace the sentence, e.g. by “… as the reference point for evaluating 
the risk following acute oral exposure”.  
 
line 2936, page 109 (3.1.6.1.1): “Results from limited 
developmental toxicity studies…” It is recommended to specify whether 
a limited number or quality of studies is meant.  
 
lines 2951 to 2955, page 109 (3.1.6.1.2): The last part of the 
clause “Based on the available information, the CONTAM Panel 
considered the LOAEL of 1 mg potato TGA/kg bw per day based on the 
data from case reports, outbreaks and studies in volunteers, as the 
reference point for acute exposure to potato TGAs via food” might be  
misleading to the reader. It is suggested to replace the sentence, e.g. 
by “… as the reference point for evaluating the risk following acute oral 
exposure”. 
















data on food 
lines 3184 to 3197, page 118 (3.2.2.1.1): The paragraph is an 
exact text duplicate from page 116, lines 3164 to 3177. It appears that 
this paragraph has to be deleted. 
 
line 3309, page 123 (3.2.2.1.1): The term “consumption potatoes” 
in the header of table 32 might be replaced by “table potatoes” or 
“potatoes for human consumption”. 
 
line 3313, page 124 (3.2.2.1.1): Missing blank space in the header 
of table 33: “Totalglycoalkaloids” has to be replaced by “Total 
glycoalkaloids”. 








Editorial suggestion implemented.  








Chapter Comment(a) EFSA response 





lines 3728 and 3729, page 143: The term “dietary acute exposure” 
might be replaced by the more common “acute dietary exposure” that 
is also used in the rest of the opinion. 
 
line 3732, page 143: The term “acute risk assessment” is misleading 
as it might be interpreted as a preliminary ad-hoc assessment. The 
term could be replaced, e.g. by “assessing the risk following acute 
exposure”. 
 
table 42, page 143: The word “durvey” needs to be replaced by 
“survey”. 
 
lines 3755 to 3756, page 144: The text of the figure header is 
difficult to interpret: “Mean daily amounts of main-crop potatoes (grams 
per day) calculated on consumption days by food source category for 
Adults and Todders across the different surveys.” 









The spelling has been corrected. 
 
 








line 3788, page 145: The term “mean acute estimates” should be 
replaced by “mean acute exposure estimates”. 
 
line 3794, page 145: The phrase “Median (and upper 97.5% 
confidence limit) chronic estimates of intake…” should be replaced by 
“Median (and upper 97.5% confidence limit) estimates of chronic 
intake…”. 
Editorial suggestion implemented.  
 
 




18 3.4.1.1. GA 
from edible 
parts of S. 
tuberosum 
line 3843, page 147: “Margin of exposure (MOE) values for the range 
of acute mean and P95 exposure assessment across different studies”. 
It is suggested to delete the word “assessment” in this header of table 
43. 
 
lines 3853 to 3854, page 147: The header of table 44 “Summary 
statistics of the % of survey days with an intake of potato TGAs below 
the margin of exposure (MOE) of 10 calculated only for the days of 
potato consumption…” might be replaced by “Summary statistics of the 
% of survey days with an intake of potato TGAs leading to a margin of 
exposure (MOE) of below 10 calculated only for the days of potato 
consumption…”. 
 






















Chapter Comment(a) EFSA response 
lines 3856, page 147: The phrase “(a) The mean percentage of days 
below the MOE of 10…” should be replaced by “(a) The mean 
percentage of days with intakes leading to MOE values of below 10…”. 
Editorial suggestion implemented. 





lines 3950 to 3952, page 150: The clause “Differences in absorption 
and excretion were observed for these two GAs in rats and hamsters, 
…” should be replaced by “Differences in absorption and excretion 
between rats and hamsters were observed for these two GAs,…”. 
Editorial suggestion implemented.  




lines 4049 to 4050, page 153: The phrase “…, as the reference 
point for the acute risk characterisation” might be replaced by “…, as 
the reference point for assessing the risk following acute exposure”. 
Editorial suggestion implemented.  
21 Appendix B lines 5144 and 5168/5169, page 185; lines 5191/5192, page 
186; lines 5214/5215, page 187 (B.1): It is confusing why the 
final number of hits regarding adverse effects of gylcoalkaloids in 
humans after removal of dublicates is 330 as mentioned in line 5144 
whereas the search for the terms “solanine”, “chaconine”, 
“glycoalkaloids” in this regard yielded 356, 206 and 541 hit after 








line 5225, page 187 (B.1): The listing has to be started with tomato 
alkaloids here as bullet point a. 
The final number of hits 330 refers to the 
combination of the final identified papers for the 
three searches (Solanin*, Chaconin* and GAs) 
from the three databases Pubmed, Scopus and 
Web of Science without duplicates (single 
unique entries from the three databases 
combined, (356 Solanin*, 206 Chanconin* and 
541 for the search of general Glycoalkaloids). 
Those three results (a total number of 1,103) 
were combined in a single folder and further 
screened for duplicates. The final number of 
single entries for the searches resulted in 330 
papers. 
 
Editorial suggestion implemented. 
22 Appendix H line 5311 (Table H.1): The phrase “(a) The mean percentage of days 
above the LOAEL…” might be replaced by “(a) The mean 
percentage of days with intakes above the LOAEL…”. 
Editorial suggestion implemented.  








Chapter Comment(a) EFSA response 
23 Other With reference to the List of authors (lines 5 and 7, page 1): Dieter 
Schrenk is mentioned twice as author. 
 
With reference to chapter no. 1.1 (lines 365 and 370, page 11): The 
family name of plants (here: Solanaceae) should be written in normal 
instead of italic letters as it is consistently done in the rest of the 
opinion. 
Editorial suggestion implemented. 
 
 
Editorial suggestions implemented. 
Max-Rubner 
Insitute 
24 1. Introduction lines 384-385, page 11 (1.1): Bitter and burning sensation is in this 
circumstance described as a symptom associated with GA poisoning 
and thus appears in this sentence to be a clinical symptom. From 
another point of view, bitter taste and burning sensation are terms that 
are used as sensory descriptors. This discrepancy could be solved, if the 
first part of the sentence would be rewritten; e.g. “Bitter or burning 
sensation in the mouth are sensory impressions which may accompany 
glycoalkaloid poisoning symptoms from potatoes that include flu-like 
symptoms such as nausea, vomiting, …” 
Since this comment refers to Section 1.1. 
Background and Term of Reference as provided 
by the requestor, the requestor (EC) has been 
consulted and the text has been modified 
according to the suggestion.  
25 1.3.1. 
Chemistry 
lines 428-447, page 12-13: This section deals with the chemical 
structure of the relevant alkaloids referring to the Appendix A. It is 
noticed that no literature is cited in the section mentioned. It is 
recommended to proof if there really is no need for including a 
reference. 
Some references to relevant reviews have now 
been added to Section 1.3.1 of the Opinion. 
26 1.3.3.1. 
Potatoes 
lines 619-621, page 17: Localization and development in skin and 
sprouts was visualized impressively by Ha et al. using MALDI-TOF. 
(Ha, M., Kwak, J. H., Kim, Y., & Zee, O. P. (2012). Direct analysis for 
the distribution of toxic glycoalkaloids in potato tuber tissue using 
matrix-assisted laser desorption/ionization mass spectrometric imaging. 
Food Chemistry, 133(4), 1155-1162.) This reference is suggested to 
take into account. 
 
line 670, page 20: The sentence seems to contain a syntax error. 
It is recommended to delete “as to”. 
The CONTAM Panel acknowledges this 
information. A sentence describing the work of 
Ha et al. (2012) has now been added to Section 





Editorial suggestion implemented. 








Chapter Comment(a) EFSA response 
27 1.3.3.2. 
Tomatoes 
lines 681-682, page 20: There are data from 2018 available. 
It is recommended to actualize the FAO data on production. 
 
 
lines 704-731, page 21: In this chapter, several references have 
been cited that show the GA concentration in developing tomato fruit 
tissue. Additionally, there is a holistic work on this topic available that 
was performed by Moco et al. using a metabolomic approach. 
Moco, S., Capanoglu, E., Tikunov, Y., Bino, R. J., Boyacioglu, D., Hall, 
R. D., ... & De Vos, R. C. (2007). Tissue specialization at the metabolite 
level is perceived during the development of tomato fruit. Journal of 
Experimental Botany, 58(15-16), 4131-4146. It is suggested to proof if 
the work performed by Moco et al. could complement the chapter. 
The Opinion has been updated with the FAO 
data on potato, tomato and aubergine 
production in 2018. 
 
The CONTAM Panel acknowledges this 
information. The work of Moco et al. (2007) has 
been incorporated in Section 1.3.3.2 of the 
Opinion. 
28 1.3.4. Previous 
risk 
assessments 
line 843, page 24: Literal error:…”levels”. “level” in the singular form 
would be correct. 





line 1059, page 29: Literal error:…”reductions”. “reduction” in the 
singular form would be correct. 
Editorial suggestion implemented. 
30 3.1.2.1. Acute 
toxicity studies 
line 1372, page 37 (3.1.2.1.2.): … “900–1,000 mg/kg bw”. The 
value is assumed to be related to tomatine, but it is not mentioned in 
the text. 
 
line 1377, page 37 (3.1.2.1.2.): … “6,316 mg dw”. The unit seems 
to be incorrect. It is expected “mg/kg dw” 
 
lines 1391-1392, page 38 (3.1.2.1.3.): This sentence is redundant 
with the sentence in lines 1396-1397. The sentence may be deleted in 
lines 1391-1392. 
 
lines 1408, 1409, page 40 (3.1.2.1.3.): Table 7, row 3 (observed 
effect), in line 11 it is written “lower blood”. “lower” should be 
exchanged by an arrow (↓ ). 
The sentence has been revised to clarify to what 
it refers.  
 
 
Units have been corrected.  
 
 








lines 1524-1527, page 46 (3.1.2.2.1.): Which amount of GAs was 
applied to the experimental animals? 
The estimated intakes of GAs in mg/kg bw/day 
are now given in the text. 














line 1689, page 60 (3.1.2.3.1.1.): The sentence seems to contain a 
error as GD8 appears two times. It is recommended to delete “on GD8” 
at the sentence end. 
 
lines 1712-1713, page 61 (3.1.2.3.1.1.): “Maternal death was 
observed for 4 and 6 dams respectively, …” The size of the population 






lines 1861-1862 and 1869-1871, page 64 (3.1.2.3.2.): It is 
suggested to add the information about the length of the application 
period. 




The CONTAM Panel could not find any indication 
for the number of dams treated per group in the 
study. The best estimation is, that the total 
group size is represented by the sum of the 
number of dead dams, resorbed litters and live 
litters reported, assuming that each dam 
investigated was pregnant. For consistency, the 
same information was also added for -solanine. 
 
 
The duration of both experiments was 30 days. 
This information is now added in the description 




line 1931, page 76: It should be proven if solanidine is to be added 
in this conclusion. 
The study by Emmanuel et al. (2006, abstract 
only) referred to solasodine and not solanidine, 
as wrongly indicated in the text. This error has 
now been corrected and the conclusion does not 
need to be amended.  
34 3.1.2.7. 
Genotoxicity 
lines 1986-1984, page 77 (3.1.2.7.2.): A statement on tomato GAs 
should be included to stay congruent with the other chapters. 
A sentence has now been added in Section 
3.1.2.7.2 to clarify that no studies could be 
identified investigating the genotoxicity of 





line 2014, page 82: Literal error: Two times “that” is written in the 
sentence. 




lines 2092-2094, page 84: If the cooked, peeled potatoes contain 
240 mg Solanine per kg and the intake of soldiers is estimated to be 
300 mg Solanine, this means that the soldiers would have eaten more 
than 1 kg of potatoes in their meal. This amount seems too high. 
It is suggested to proof the amount consumed by the soldiers in the 
original reference. 
The amounts and values indicated in the 
description of the Pfuhl (1899) study are 
correctly reported.  
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37 3.1.3.1. GAs 
from S. 
tuberosum 
line 2202, page 86 (3.1.3.1.2.): The last part of the sentence 
(“,…assuming a weight of 150 g per potato”) could be omitted, as the 
content does not provide the reader with substantial information in this 
context. 
The part of the sentence indicated has now 
been deleted.  
38 3.1.4.2. Pigs lines 2357-2362, page 92: It seems to be questionable if the potato 
protein contains enough GA to cause symptoms after consumption 
by the tested pigs. The study does not contribute to the overall 
conclusions. 
The CONTAM Panel agrees that the study does 
not contribute to the overall conclusion. The 
study was mentioned to demonstrate the 








line 2714, page 104 (3.1.5.1.3.): “in processes of neuronal and 
non-neuronal developmental…” There seems to be a literal error. 
The sentence has now been revised and the 





line 2553, page 100: “…body fluids and concentrations used to 
study…”. It could be added if the inhibitor or the substrate 
concentration was meant here (or both). 
The sentence has been revised to clarify the 
meaning.  
41 3.1.6.1. GAs 
from edible 
parts of S. 
tuberosum 
line 2812, page 106: “Bitter taste, gastric discomfort and nausea 
may occur within ~30 min after ingestion of ~1 mg potato TGA/kg 
bw contained in a potato meal”. In contrast to the symptoms 
mentioned, the bitter taste is not dependent on the GA dosis per kg bw. 
The taste threshold is dependent on the concentration in the food 
matrix. 
 
line 2864, page 107: “based on the likelihood to develop diarrhoea 
after ingestion of potato TGA, humans show an approximately 
300-fold higher susceptibility (towards this adverse effect of potato 
TGA) than rats.” The last part of the sentence contains redundant 
information and could be deleted. 
 
lines 2919-2921, page 108 - 109: “To conclude, the data available 
for repeated dose toxicity are not sufficient to identify a reference point 
for chronic exposure to potato GAs.” This sentence is redundant with 
the sentence in lines 2927-2928, and could be deleted. 
According to the suggestion, reference to bitter 






The Panel agrees that a part of the sentence is 





According to the suggestion, the sentence has 
now been deleted to avoid the redundancy. 













lines 3003-3008, page 111: The data collection is explained in this 
paragraph: “Data were reported on samples collected between the 
years 2005 and 2017.”. Looking at Table 28 there is a gap of data 
submission to the study from 2008 until 2014. Could an 
explanation be given for this gap? 
Data are submitted by data providers on a 
voluntary basis upon an annual generic call for 
data by EFSA. The gap seems due to the fact 
that data on GAs are not regularly/systematically 
collected nor submitted to EFSA. See also reply 




data on food 
lines 3313-3314, page 124: Page 124, Table 33, headings of row 5 
(TGA average) and 6 (Range). Are the units fw or dw based? 
The concentrations are based on fresh weight. 





data in feed 
line 3366, page 126 (3.2.2.1.3.): … “1,402-2,210 mg fw” 
The unit seems to be incorrect. It is expected “mg/kg fw”. 
  
line 3399-3401, page 127: “No surveys on the levels of GAs in 
potatoes and potato by-products used as feeds for livestock have 3400 
been identified in the open literature.” Should the companion animals 
be added here? 
Editorial suggestion implemented. 
 
 




factors on the 
content of GAs 
lines 3430 - 3432, page 132: “Factors that influence the content of 
GAs pre-harvest have been briefly described in Section 1.3.3 and 
3.2.2.1.1.” Could the paragraph 3.2.3. be omitted? 
The Panel acknowledges that Section 3.2.3 of 
the version of the draft opinion under public 
consultation does not add new information, and 
thus it has been deleted from the final version of 
the Opinion.   












lines 3469 - 3483, page 132 - 133 (3.2.4.1.1.): This paragraph 
deals with packaging and light conditions during storage as well as with 
application of sprout suppressants. A compatible study was performed 
by Haase (2010) emphasizing the importance of sprouting on GA 
formation. Haase, N. U. (2010). Glycoalkaloid concentration in 
potato tubers related to storage and consumer offering. Potato 
Research, 53(4), 297-307. It is suggested to proof if the work 
performed by Haase (2010) could complement the chapter. 
 
lines 3469 - 3483, page 132 - 133 (3.2.4.1.1.): Another 
publication is to be mentioned in this context: Olsen, N. L., et al. 
(2018). "The Impact of Retail Light Source on Greening of 
Russet Burbank Potato Tubers." American Journal of Potato 
Research 95(2): 123-129. This reference is suggested to take into 
account with regard to the influence of consumer offering which is 
considered being of high practical relevance. 
 
lines 3474 - 3475, page 133 (3.2.4.1.1.): “…although other studies 
have reported that potatoes stored in polyethylene bags showed higher 
GA levels that those packaged in mesh or paper (Gosselin and Mondy, 
1989).” “although” indicates a contradiction. However, if the 
transmission of light that induces GA formation is lower for mesh or 
paper, there seems to be no contradiction. 
The CONTAM Panel acknowledges this 
information and the study has been added to 
Section 3.2.3.1 of the Opinion for completeness 






The CONTAM acknowledges this information and 
the study has been added to Section 3.2.3.1 of 






The sentence has been revised to delete the 









lines 3688-3689, page 142: “Freeze-drying of the produced tomato 
homogenate and subsequent storage for 4 weeks at room 
temperature, resulted in a reduction of the tomatine content of 82–
85% (Kyzlink et al., 1981).” Does the calculated reduction include a 
correction of moisture loss? 
Yes, the calculated reduction takes the moisture 
loss into account. The sentence has been 
rephrased to make this clearer. 





lines 3739 - 3744, page 143: Table 42, line 1: “Range across 
durveys…” There seems to be a literal error: surveys.  
 
lines 3755 - 3757, page 144: Figure 8 The colors of some of the 
food sources are difficult to distinguish. The y and x-axis are small and 
difficult to read. 
The spelling has been corrected.  
 
 
The format of Figure 8 has been revised for a 
better readability.   
49 3.4. Risk 
characterisatio
n 
line 3840, page 146: “Comparison of the acute exposure estimates 
(see Table 43) to the”. There seems to be a literal error: Table 42. 
Editorial suggestion implemented. 
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50 References line 4223, page 157: Literal error: ”…the effect of variety and 
drought stress on thea-solanine and a-chaconine contents of 
potatoes. Journal of the”… Instead of “thea” an “a” 















See Annex A of 
this Technical 
report.] 
51 Summary Page 6, recommendations section lines 223-240: 
• In addition to the listed recommendations, we recommend also 
determining the link between greening on potatoes and processed 
potato products and the association with glycoalkaloid content. 
Glycoalkaloids can vary widely due to environmental and genetic 
factors, and can be elevated in certain varieties of stresstolerant 
potatoes and this increase in glycoalkaloid content is not associated 
with potato greening or increased toxicity. Glycoalkaloids are used as 
an indicator of toxicity due to greening in many markets, and 
the association between greening and glycoalkaloid content should be 
determined to understand if incidental potato greening is a health risk. 
 
• Determine factors that increase glycoalkaloids and potential mitigation 
measures. Storage conditions, such as lighting and temperature can 
impact glycoalkaloid levels in raw potatoes, and chemical treatments 
such as detergents and sprout inhibitors decrease glycoalkaloid 
concentrations in raw potatoes. Additionally, processing factors, such as 
peeling, boiling, frying, and dehydrating potatoes significantly 
impacts glycoalkaloid concentrations. These different treatments should 
be factored in when determining acceptable glycoalkaloid levels in the 
finished product. 
 
• Animal toxicology and metabolism studies can be difficult to 
extrapolate to humans due to differences in the route of exposure, 
metabolism, and other biological factors of the test animal that do not 
translate to humans. We recommend ascending dose clinical toxicology 
and toxicokinetic studies using processed potato products with 
established glycoalkaloid concentrations to determine a lowest observed 
and no observed effect level for glycoalkaloids; the reference dose 
should be based on human toxicity and metabolism via the oral route of 
exposure with the estimated dietary intake of the processed potato 
product using data on amounts and frequency of product consumption. 
 
Further information about the evidence available 
on the link between greening (i.e. chlorophyll 
formation) and increase in the levels of GAs has 
now been added in Section 3.2.3.1.1 of the 
Opinion. A direct relationship between greening 
of the potato tubers and increase in the GAs 
levels has not been established, and depends on 




Establishing maximum levels of GAs in finished 
products is a risk management measure and it is 








The CONTAM Panel followed the strategy, as 
outlined by EUPPA: toxicokinetic and 
toxicodynamic studies on human volunteers and 
human observation studies with oral uptake of 
specified doses of GAs were used by the Panel 
to establish a reference dose. For further details 
please see Section 3.1.6.1 of the Opinion on 
‘Considerations of critical effects and dose-
response analysis for the human risk 
assessment’ and Section 3.4 on ‘Risk 
Characterization’.  
 













Page 111-112: It is not clear which potato varieties have been used 
for the study and whether long term stored potatoes have been 
assessed in the study 
In the exposure assessment made by EFSA all 
available table potato varieties were used. No 
sufficient data were available to compare 
occurrence in different varieties and no 
information about the length of the storage was 
available in the occurrence dataset submitted to 




data in feed 
Page 124, Table 33: The sample sizes used to determine the average 
glycoalkaloid levels for processed potato products is very small and 
should be increased to a statistically significant sample size. This data 
does not take into account the different varieties of potatoes and 
associated glycoalkaloid levels, as glycoalkaloid levels can vary 
significantly across varieties. We recommend gathering data on these 
products using statistically significant sample sizes as well as 
accounting for variety-specific glycoalkaloid levels, as well as water 
content of the product. This would provide a more accurate 
representation of glycoalkaloid levels in the finished good. 
The CONTAM Panel agrees that the available 
data from the literature on GAs in processed 
potato products is very limited and for a large 
part also dated. The Panel had identified the 
lack of occurrence data on GAs and their 
aglycones in potato processed products, 
including foods for infants as an important need 
and therefore had made a recommendation (see 
Section 5 of the Opinion).  
 
The Panel acknowledges the occurrence data 
submitted by EUPPA in the context of this public 
consultation. Due to time constraints, EFSA 
cannot use additional occurrence data submitted 
during the public consultation for the dietary 
exposure assessment in this risk assessment. 
However, occurrence data submitted in SSD 
format will be stored and considered for future 






the content of 
GAs 
Page 135, lines 3574-3576 
Dehydration of potatoes can increase glycoalkaloid concentrations due 
to water loss creating a concentrating effect in processed potato 
products, such as potato flakes and potato flour. A concentration factor 
for glycoalkaloids in dehydrated potato products is recommended to 
account for concentration increases that occur as a result of water loss. 
This same factor adjustment is used for pesticides that concentrate in 
dehydrated potato products, such as pesticides in potato flakes and 
chips, allowing a higher residual level in the processed product to 
account for water loss. 
 
Dehydration of potatoes may result in increased 
concentrations of GAs in the product. The effect 
of dehydration is corrected for when the 
processed food products are converted to their 
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Considering that potato flakes undergo additional processing, the 
allowable limit of glycoalkaloid concentration should be increased since 
further processing occurs. Potato flakes are used in mashed 
potatoes and some potato chips, formed potato products, and as 
thickeners in soups, gravies and sauces. The final glycoalkaloid 
threshold should be based on glycoalkaloid concentration in the finished 
products and potential toxicity. 
 
Processing of potatoes may result in changed 
concentrations of GAs in the final product. This 
is corrected for when the processed food 
products are converted to their corresponding 
quantities in the RPC database. The 
establishment of maximum limits for GAs in 
potato products as well as for the raw 
commodities is a risk management measure and 
it is outside the remit of EFSA. 








The peel (skin) of our potatoes, together with other potato by-products 
as a result of our manufacturing process, have feed as a final 
destination. As already mentioned, there is a high concentration of 
glycoalkaloids in the skin of tubers. In case of a MRL will come into 
force, is there a possibility that a factor will also come for feed? This 
will be also a challenge for us to be able to comply with. 
Establishing maximum levels of GAs in finished 
products is a risk management measure and it is 
outside the remit of EFSA.  
 56 Other 
comments 
It is important to highlight what the industry does to prevent green 
potatoes to enter the food chain: Camera detection in several points in 
the processing line (incoming, after peeling, after cutting). 








57 Summary Line 123-125: “Further symptoms, including drowsiness, apathy, 
confusion, weakness, vision disturbances, rapid and weak pulse, and 
low blood pressure may be the consequence of dehydration.” What is 
meant? That other symptoms could not be due to GAs? Or do you 
mean to say that the signs and symptoms from dehydration are hard to 
separate from neuro-effects? 
The sentence has been modified to clarify that 
these symptoms maybe the consequence 
following vomiting and diarrhoea caused by GAs.  
58 3.1.3.1. GAs 
from S. 
tuberosum 
The heading in 3.1.3.1.4 “conclusions” should rather be “summary” 
since the conclusions of the risk assessment come later. 
Editorial suggestions implemented.  
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59 3.1.6.1. GAs 
from edible 
parts of S. 
tuberosum 
Why were the human data considered insufficient? What does the 
CONTAM Panel think would be sufficient to establish an ARfD? The 
reason for saying the data are insufficient is not explained in 3.1.6.1.2. 
However, the Panel is quite specific in which MOE that is needed to 
conclude no health concern. (“An MOE higher than 10 indicates that 
there is no health concern”). It seems thus that an ARfD could have 
been established based on the available data. 
 
Why was it considered necessary with an UF of 3 to extrapolate from 
LOAEL to NOAEL? It is reasonable that 1 mg/kg bw can be considered a 
LOAEL based on Harvey et al. (1985) with none of three affected (only 
bitter taste) and Hellenäs et al. (1992) with 6 out of 7 volunteers 
affected (nausea, however, could also be placebo effect). The study by 
Mensinga et al. (2005) indicates however that 1 mg/kg bw is close to a 
NOAEL. The participants received potato TGA at 0.3, 0.5, 0.7, 0.95, 
1.10 and 1.25 mg/kg bw, and one out of two participants at the top 
dose showed effects. Although the number of participants in each dose 
group is low, it seems that even an UF 2 would be more than sufficient 
to extrapolate from LOAEL to NOAEL. We fully agree an UF of 3.2 for 
toxicodynamic differences is needed. 
The human data were considered insufficient to 
establish an ARfD since from none of the studies 
in human volunteers with oral administration of 
GAs in an adequate matrix, such as a potato 
meal, a NOAEL could be identified. Furthermore, 
no data indicating a NOAEL in children were 
available. 
 
In Mensinga et al. (2005) the outcome of the 
study arm in which TGA was administered in 
solution in doses of 0.3, 0.5 and 0.7 mg/kg bw 
is considered to be only of limited relevance 
since it does not reflect realistic conditions of 
exposure to GA in the presence of a potato 
matrix. From the subjects receiving 0.95, 1.10 
and 1.25 mg TGA/kg bw in mashed potatoes, 
one of the two subjects in the high dose group 
developed nausea and started vomiting. In the 
view of the CONTAM Panel, the results of this 
study show that a dose as low as 1.25 mg/kg 
bw may induce adverse effects in certain 
individuals. However, the study design and in 
particular the low number of volunteers per 
group does not allow to draw exact conclusions 
on dose-adverse effect-relationships. Therefore, 
an UF of 3 is considered adequate to take the 
existing uncertainties into account when 







60 Summary RIVM would like to congratulate EFSA on the work done and we hope 
that our comments will be of use in the finalization of the opinion. 
 
Line 179: EFSA states: ‘…reduction factors for the major food  
processing steps…’. In other frameworks (e.g. PPR) these are called 








To avoid confusion, in the context of exposure 
calculations the term ‘processing factor’ has now 
been used instead of ‘reduction factor’. In the 
context of the effect of processing on the TGA 
content the term ‘percentage reduction’ has 
been used instead of ‘reduction factor’. 
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Lines 179-183: EFSA states: ‘For the exposure assessment, reduction 
factors for the major food processing steps, comprising peeling and 
heat processing (boiling, frying, baking), were applied to the occurrence 
data as follows: reduction factors between 0.25 and 0.75 were 
attributed to the peeling of potatoes, between 0.2 and 0.9 for frying 
and deep frying, and between 0.05 and 0.65 for all other cooking 
methods.’ Lines 177-178 also provide processing factors for microwave 
cooking and oven baking, but these processing factors were 
not used in the exposure assessment. Could you please motivate in the 
relevant section of the opinion why the processing factors for 
microwave cooking and oven baking were not considered in the 
exposure assessment. 
The selection of processing factors is described 
in Section 2.5 of the Opinion on ‘Methodology 
for exposure assessment’ and is based on the 
available literature presented in Section 3.2.4. 
Unfortunately, in the RPC Consumption 
Database no specific information is available for 
microwaving and baking events, only for cooking 
in water (and stewing).  For this reason, it is not 
possible to use specific processing factors for 
baking and microwaving in combination with the 
RPC Consumption Database. The available 
literature furthermore indicates that there are 
only small differences between processing 
factors for boiling (0.35–0.95), microwaving 
(0.55–0.95), baking (0.5–0.8) and drying (0.38-
0.71). It is therefore reasonable to assume that 
the processing factor for boiling covers that of 
baking and microwaving as well as drying heat 




















From the description of the text in section 2.5, we gathered that 
CONTAM Panel estimates the acute exposure by combining the daily 
consumption patterns of foods by one randomly selected concentration 
value for the relevant foods, which was combined with a randomly 
drawn processing factor, resulting in one acute exposure per 
consumption day. This is done for all consumption days available per 
age group and survey, resulting in a distribution of acute exposures. 
The number of acute exposures is defined by the number of days in an 
age group and survey at which potato(products) are consumed. 
Consequently, this is repeated a 1000 times, resulting in 1000 
distributions. These 1000 distributions are subsequently used to 
calculate the mean and P95 exposure, and to derive uncertainty 
intervals around these ‘ best estimates’. Assuming that the above 
description indeed describes the procedure taken by CONTAM Panel to 
assess the acute exposure, we have several observations regarding this 
procedure: 
 
1. The PPR panel published in 2012 a Guidance on the Use of 
Probabilistic Methodology for Modelling Dietary Exposure to Pesticide 


















The Guidance on the Use of Probabilistic 
Methodology for Modelling Dietary Exposure to 
Pesticide Residues was not used as such 
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could be relevant for contaminants too. Did the CONTAM panel use this 
Guidance? If so, could you please refer to this Guidance. If not, could 
you please make clear why this guidance was considered as not 
relevant for the current risk assessment of glycoalkaloids. 
 
2. The text of the draft opinion suggests that the probabilistic approach 
includes random sampling of concentration data and processing factors 
and the assumption of peeling potatoes, but not for random of food 
consumption data. As described in the 2012 Guidance mentioned 
earlier, also food consumption data should be randomly sampled as 
part of a probabilistic acute exposure assessment. If this interpretation 
is correct, could you please explain why consumption data were not 
randomly sampled? If this interpretation is not correct, could you please 








3. If consumption data were not randomly sampled, the approach is 
semi-probabilistic rather than full probabilistic. In this case, we suggest 
addressing why EFSA denominates the approach as probabilistic 
rather than semi-probabilistic.  
 
4. Was random sampling of input data performed with replacement? If 
so, please clarify this in section 2.5. 
 
5. If the above described interpretation of the exposure assessment is 
correct, the 1000 intake distributions generated per age and survey 
describe the possible variation in the exposure using different 
concentration data. Consequently the confidence interval is not an 
uncertainty interval but describes the variation in the exposure due to 
variation in the different input variables. To attain a confidence interval, 
the bootstrap methodology for quantification of uncertainty (proposed 
in the EFSA Guidance on the Use of Probabilistic Methodology for 
Modelling Dietary Exposure to Pesticide Residues published in 2012) 
should be used. It seems that in the draft opinion, variation has been 
(considering that it applies to pesticide residues 
and not to contaminants). An analogous 
methodology was used (see replies below within 
this comment).   
 
The methodology used was based on random 
sampling of the occurrence data, of the 
processing steps where the information was not 
available, and of the processing factors. Random 
sampling of consumption events was not 
performed because potatoes are a widely 
consumed food and GAs are present in all 
samples. Thus, the CONTAM Panel concluded 
this would have a limited impact on the results. 
By only random sampling of occurrence and 
processing factors, results looked stable already 
after 500 iterations. Section 2.5 of the Opinion 
was now been revised to make this clearer. 
 
There is not a universal convention for what can 
be defined as semi-probabilistic or probabilistic. 
The CONTAM Panel finds that the term 
‘probabilistic’ can be considered appropriate and 
the variables that have been randomly sampled 
are described in Section 2.5 of the Opinion.  
 
Replacement was used and this has been now 
clarified in Section 2.5 of the Opinion.  
 
The interpretation is correct but the 1,000 
iterations and related confidence interval 
describe the uncertainty, not the variation. The 
variation is captured by randomly sampling the 
occurrence and processing factors within each 
iteration. Thus, the distribution obtained in each 
iteration captures the variability linked to 
consumption and occurrence. The 1,000 
iterations capture the uncertainty around the 
results of each iteration. 
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assumed as uncertainty. Please consider revising the text if this is 
correct or clarify the text to avoid confusion. 
 
Line 1051 (EFSA 2011b): Please note that the reference EFSA 2011b 
refers to a report on the development of a food classification and 
description system for exposure assessment and guidance on its 
implementation and use (EFSA Journal 2011;9(12):2489. [84 pp.]) and 
not to a probabilistic approach. We suggest inserting the correct 
reference here. EFSA might have meant to refer to the ‘Guidance on 
the Use of Probabilistic Methodology for Modelling Dietary Exposure to 
Pesticide Residues’ (doi: 10.2903/j.efsa.2012.2839). 
 
Lines 1060-1071: It is not clear from the text whether two different 
processing factors were used for e.g. cooked peeled potatoes (first one 
for peeling and the second one for cooking). We suggest clarifying this 
in the text. 
 
Lines 1066-1069: EFSA states ‘…drying, flaking and roasting : 5% 
each.’ It is unclear to RIVM whether processing factors between 0.05 
and 0.65 % were assigned to drying, flaking and roasting. These 
processes may occur at temperatures different from cooking in water. 
What was the rationale to assign the processing factor of cooking in 
water to drying, flaking and roasting? Could you please explain which 
processing factors were assigned to drying, flaking and roasting and 









Lines 1066-1069: Frequencies of processing: are these frequencies 
obtained for each country or across countries? In case of across 
countries: are any (cultural) differences in processing frequencies to be 






The reference was indeed incorrect and has 
been deleted. Clarification has been introduced 
in the text regarding the exposure assessment 






The text has been amended to clarify the 




Due to the lack of suitable studies no processing 
factors for roasting could be established. With 
respect to drying (dehydration processes, 
including production of flakes or granules) a 
number of studies were identified, that have 
now been added to the Opinion (Section 3.2.3). 
From the available studies it could be derived 
that in a (semi)-industrial setting the reduction 
due to drying is in the range of 29% to 67%. 
This range is not that much different from what 
has been found for boiling and steaming. 
Therefore, also considering that dried products 
represent only 10% in the Comprehensive 
Consumption Database, it was decided to use 
the same processing factors in the exposure 
calculations.  
 
An overall processing frequency across countries 
was obtained. Unfortunately, due to the limited 
information available it was not possible to 
characterise differences in processing 
frequencies among countries.  
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Lines 1084-1096: The P95, that was also determined by EFSA is not 
mentioned here. We suggesting adding that the P95 was assessed in 
section 2.5. 
 




P36 Lines 1314-1315: Here it is stated that both α-solanine and α-
chaconine have long serum half-lives, suggesting a possible 
accumulation. Could EFSA further elaborate if this is covered by the 
MOE of 10 for acute effects? Some consumers may eat potatoes on a 
daily basis, for high consumers this may be large amounts. When also 
the TGA concentration is high, this may lead to high exposure. Due to 
the long half-life accumulation may occur over the days. According to 
line 2060 on p83, signs of intoxication may also occur with a latency 
period up to two days. Taken together, should also exposure on 
previous days be taken into account in this case? We are aware that 
strictly speaking this is generally not done in a risk assessment of 
acute exposure. 
After a single intake of 1/0.95 mg GA/kg bw via 
mashed potato meals, reported half-lives of -
solanine and -chaconine were in the range of 
9.6–13.9 h and 16.9–21.1 h (n = 7; Hellenäs et 
al., 1992), and 14–18 h and 27–49 h (Mensinga 
et al., 2005; n = 3), respectively. This indicates 
considerable variability. Experimental human 
data on repeated exposure are lacking. The MOE 
of 10 takes into account the interindividual 
variability in toxicodynamics (factor of 3.2) and 
extrapolation from a LOAEL to a NOAEL (factor 
of 3), considering that the acute local effects in 
the gastrointestinal tract may be predominant.  
With respect to chronic exposure, it should be 
noted that findings related to current 
consumption habits of potato GAs are 
suggesting no association with adverse health 
effects at levels not causing acute effects. 
Nevertheless, the CONTAM Panel states that the 
potential for bioaccumulation should be better 
characterised in additional toxicokinetic studies, 
as stated in the Recommendations.  














P64 lines 1873-1876: in these lines it is said that doses of 
approximately 3.6 mg/kg bw per day of α-solanine resulted in a much 
lower percentage of successfully weaned pups compared to controls. 
The observed decrease is most likely due to lactational failure. This 
dose is much lower than the dose where acute effects takes place in 
rats (300 mg/kg bw and above). As humans are much more sensitive 
towards the acute effects than rats, EFSA is requested to discuss in the 
opinion if it is expected that similar effects on lactation may also occur 
in humans? 
This is one reported study. It was conducted in 
1961, and has never been followed up. From the 
results of the short, 3-page paper it is not 
possible to discuss whether similar effects may 
occur in humans. Therefore, a recommendation 
was made by the CONTAM Panel that more 
studies are needed. In addition, there are 
several shortcomings which need to be 
addressed in future studies. These include the 
following: (i) Lactational failure was proposed as 
cause for the death of the pups, because their 
stomachs contained no milk. Cross fostering 
failed in a first attempt and was not taken up 
again. (ii) A mechanistic endocrine link between 
GAs exposure and lactation is not available. (iii) 
No food consumption records were kept. (iv) No 
precise date for the onset of exposure is given, 
quotation: “as soon as pregnancy was indicated 
by increase in weight”. Consultation of a 
veterinarian doctor revealed that weight gain 
becomes detectable in pregnant rats only from 
the 2nd trimester onwards. (v) No duration of 
exposure is given, quotation: “some of the rats 
were on test diets for only a few days before 
dropping their first litter. They were then kept 
on the test diet until they had a second litter.”  
The precise procedure is not specified in 
material and methods, neither is noted which 
results have been obtained from which 
approach. 
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64 3.1.6.1. GAs 
from edible 
parts of S. 
tuberosum 
3.1.6.1.2. Derivation of a health-based guidance value (HBGV) or 
margin of exposure (MOE) approach 
 
P109 Lines 2959-2961: It is stated that an MOE higher than 10 
indicates that there is no health concern. This MOE of 10 takes into 
account the interindividual variability in toxicodynamics and 
extrapolation from a LOAEL to a NOAEL. There is however, in addition, 
only a small margin (factor 3-6) between the dose where lethal effects 
may occur and the LOAEL used for risk assessment. Lethal effects have 
indeed been occasionally seen in humans. Can EFSA further elaborate 
on the small margin between the LOAEL and the doses at which 
occasionally mortality in humans is observed in relation to an 
acceptable MOE of 10? 
 
In addition, if a specific MOE can be indicated, we would prefer to use 
this as an uncertainty factor for derivation of a HBGV. This is consistent 
with previous approaches, where weaknesses in the dataset is 
taken into account in uncertainty factors. In our opinion the MOE is 




About a century ago, fatalities were reported 
from consumption of green or unripe potatoes. 
No fatalities have been reported since in Europe. 
The risk assessment presented here is referring 
to a LOAEL which is derived from more recent 
data for which figures are less uncertain. Taking 
an MOE of 10 is considered to be protective 
already for mild and moderate adverse effects 
and by all means for the risk of fatality. 
 
 
See reply to Comment 59. 













Table 28: Sampling years of 2005, 2007, 2015 to 2017 were included 
in the exposure assessment. There is a large time gap present in the 
data and the data of 2005 and 2007 are relatively old. Why were data 
of 2005 and 2007 included? Did the CONTAM Panel check if there were 
any significant differences between values obtained from 2005 and 
2007 and those from 2015 to 2017 on the other? Please address this in 
the opinion.  
 
 
Line 3053: EFSA states that ‘The minimum and maximum reported 
concentrations were 1.1 mg/kg and 550.0 mg/kg, respectively.’ Table 
29 states a maximum of 550.3 mg/kg. We request to indicate which 





Lines 3069-3070: Numbers of non-detects are only mentioned in 
text. It would be useful to also mention the number and percentage of 
left-censored data in one of the tables. We suggest adding this 
information in Table 27 or 29 of the opinion. Also, for a good 
interpretation of the results, an overview of LODs and LOQs would be 
helpful to the reader. We suggest providing information on the range of 
LODs and LOQs in Table 27 or 29. 
 
Regarding the EFSA Guidance on the Use of Probabilistic Methodology 
for Modelling Dietary Exposure to Pesticide Residues, unit-to-unit 
variation in residues in acute assessments. Is unit-to-unit variation 
considered to be applicable for glycoalkaloids? 
See reply to Comment 42. The data from 2005–
2007 were not discarded due to the overall 
limited number of samples available. In addition, 
a comparison between the data from 2005–2007 
and 2015–2017 revealed no substantial 
differences between the levels of GAs (mean 
occurrence (UB): 49.3 and 52.3 mg/kg for the 
2005–2007 and 2015–2017 data, respectively).  
 
The CONTAM Panel has revised this value. The 
Panel noted that this value corresponded to a 
starch potato variety that is not used for human 
consumption. This sample has now been 
excluded for the dataset used to estimate the 
acute exposure and the estimates have been 
updated accordingly.   
 
The number of left-censored samples was small: 
4 analytical results for -solanine, 24 results for 
-chaconine, and in only 2 samples both GAs 
were not quantified. The range of LOQs reported 
for the left-censored results has now been 
included in the text of the Opinion and also 
included in Annex A.  
 
The CONTAM Panel considers that usually more 
than one potato is eaten, and no information on 
the unit-to-unit variation (variation among 





data on food 
The text in lines 3184-3197 is exactly the same as the text in lines 
3164-3177. We suggest deleting either of the two texts. 
The duplication has been deleted.  
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In section, 3.3.1, lines 3731 – 3732 state ‘A scenario including only 
days in which there was consumption of main-crop potatoes was 
considered the most relevant for acute risk assessment’. Please 
consider mentioning this information in section 2.5. Could you please 
also motivate why only consumption days were considered. For certain 
populations with a low potato consumption, this may reflect only a 
small number of subjects. 
 
Figure 8: lines 1079-1081 state that consumption of main-crop 
potatoes linked to the consumption of alcoholic beverages (vodka and 
spirits) was not taken into consideration as the CONTAM Panel 
considered the transfer of GAs from the potatoes during the distillation 
and refining process to be negligible. However, alcoholic beverages are 
shown in figure 8. RIVM would like to ask EFSA why this is the case? In 
addition, we find this figure hard to read and wonder if the information 
could just be summarized in the text or in a table. For details, a 
reference could be made to an annex. 
Clarifications has been added to Section 2.5. The 
rationale behind taking consumption days only, 
is that it best characterises the acute exposure. 
Consumption days available for each age group 




The format of Figure 8 has been revised for a 
better readability. The reference to the food 
category ‘Alcoholic beverages’ in this Figure has 
now been deleted according to the discussion in 







Lines 3794-3796: For chronic exposure it is not mentioned for which 
country/countries these values were applicable. Please provide this 
information. 
The countries to which the exposure estimates 
refer to have now been added. 














Lines 3916-3920: For 156 samples with unknown processing/peeling, 
the CONTAM Panel considered it unlikely that they referred to unpeeled 
potatoes. Please motivate why the CONTAM Panel considered this to 
be unlikely. Did the panel check whether the concentrations of these 















Lines 3921-3925: EFSA states that ‘The ratio between alpha-solanine 
and alpha-chaconine was found to differ between data submissions, 
indicating differences between the analytical methodologies.’ It is not 
clear to RIVM why this indicates differences between analytical 
methods. Could it (also) be natural variation? Please explain or refer to 








Lines 3921-3925: ‘Use of different analytical methods, different 
detection techniques and with varying LODs/LOQs. The ratio between 
alpha-solanine and alpha-chaconine was found to differ between data 
submissions, indicating differences between the analytical 
methodologies.’ Could you explain what is meant by different detection 
techniques and in what way detection techniques differ from analytical 
methods? We suggest adding a clarification. 
Only 7 samples from one country (Germany) 
were reported as peeled. The number of 
samples was considered too small to calculate 
an average occurrence level from these samples, 
which could be considered representative of 
peeled potatoes in the EU. A comparison 
between peeled and unpeeled potatoes could 
therefore not be made from the available 
occurrence data.  
Most of the samples were reported as 
unprocessed assuming that this also means 
unpeeled. For 131 samples (the number of 156 
mentioned in the draft opinion was incorrect) no 
information about the peeling nor the processing 
was available. These samples were considered 
unpeeled because, based on expert judgement, 
this was considered the most common way of 
sampling and testing main-crop potatoes. 
 
Figures 4 and 5 in Section 3.2.1 of the Opinion 
provide information on the distribution between 
-solanine and -chaconine for the combined 
results submitted to EFSA. At the level of the 
individual data submissions, there are 
differences in the ratio observed between -
solanine and -chaconine. This can be more 
readily explained by differences in the analytical 
methods used (e.g. sample preparation and 
detection methods) than by differences between 
varieties. This is now discussed in more detail in 
Section 3.2.1, see also comment below.  
 
The data submitted to EFSA come from only 
three countries. However, parts of the submitted 
data have been generated by different 
laboratories within a country. This can be 
deduced from the fact that for data from the 
same country different detection techniques 
have been reported for parts of the data (HLPC-















Lines 3924-3925: EFSA states ‘This is more likely to result in an 
underestimation than in an overestimation of the exposure.’ Why does 
this lead to an underestimation? We suggest referring to the relevant 
























Lines 3929-3932: ‘Literature studies, however, report a wide range of 
reduction factors, introducing uncertainty on the actual reduction during 
the various processing steps.’ Did the CONTAM Panel use the range of 
these factors into account by sampling 1000 times from that range and 
thus the uncertainty around the factors was taken into account and 
included in the confidence interval? Or did the CONTAM Panel only 
UV, LC-MS/MS, detection method unspecified or 
standard detection method). This is also the 
case for the reported LOQs, which differ 
between data submissions/parts of data 
submissions. 
 
The differences in analytical methods used may 
result in an over- or underestimation of the TGA 
content. There is indeed no reason to expect 
that this leads to an underestimation. The 
description of the uncertainty related to the 
analytical method used has now been changed 
accordingly. 
 
A related analytical issue is that there are 
indications from the literature that -chaconine 
is more susceptible to enzymatic degradation 
(producing β2-chaconine and solanidine) than -
solanine (Friedman and McDonald, 1995; Swain 
et al., 1978). Partial degradation of -chaconine 
may occur during sample preparation and 
analysis unless specific conditions are applied 
(Friedman et al., 1997; see also Section 1.3.2.1 
of the Opinion). For the datasets submitted to 
EFSA, it could not be determined to what extent 
the results for individual samples could have 
been affected by enzymatic hydrolysis. 
Enzymatic degradation could result in an 
underestimation of the exposure. This issue is 
now discussed in more detail in the Opinion in 
Section 3.2.1 and in Section 5.2 on uncertainty 
analysis. 
 
The variability of processing factors was taken 
into account by randomly sampling processing 
factors within each iteration. The uncertainty 
was taken into consideration by iterating 1,000 
times the random sampling. See also the reply 
to Comment 61, point 5.  
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take the variability in the factors into account? Also here, uncertainty 
may have been confused with variability in the exposure assessment. 
We suggest providing a clarification. 
 
Lines 3935-3937: EFSA states that ‘It is not known to which extent 
these food processing steps result in only a partial degradation of GAs 
(to β- and γ-forms of solanine and chaconine) or degradation to the 
aglycone (solanidine). This may result in a slight underestimation of the 
GA content present in food products as consumed’. EFSA is asked to 
explain this in view of the toxicity of these substances or to refer to the 
relevant section addressing the toxicity of β- and γ-forms of solanine 




Lines 3944-3946. A short summary of these uncertainties and 
limitations (as done for the food consumption data) would be helpful 





There is one study on the effects of a single i.p. 
application of solanidine in mice and two further 
studies on repeated oral toxicity of this aglycon 
in mice (see Sections 3.1.2.1 and 3.1.2.2 of the 
Opinion). Acute or repeated dose oral toxicity 
studies on β- and γ-forms of solanine and 
chaconine could not be identified. Based on this 
very limited information it is not possible to 
conclude on the toxicity of solanidine and the β- 
and γ-forms of solanine and chaconine. 
 
The text in the Opinion has been revised. The 
main uncertainties are linked to the conversion 
of the amount consumed for a specific Foodex 
code into the amount consumed of each raw 
primary commodity from which the food 




Table 45 Uncertainties: ‘Variability between countries and years’ is 
mentioned as an uncertainty. A major limitation is that data were 
obtained from only 3 countries and a large range of years. This is 
explained in lines 3910-3012, but we suggest also including this in 
Table 45. 
Table 45 has been amended as suggested.  
71 Annex A – 
Occurrence 








A3: Excelsheet of annex is called A3, while the table is numbered with 
an ‘X’. This table also contains two typo’s: please change ‘Referrig’ into 
‘referring’ and change ‘alpa’ into ‘alpha’. 
 
• Sheet of excel file is called A2 while the table is called A3. Please 
consider checking this. Also, the title contains a typo: ‘continuos’ should 
be ‘continuous’. 
The typos in Annex A have now been corrected 
and proper reference to the Annex and its tables 
has now been made in the Opinion.   
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Starch Europe 





STARCH EU is 
also available in 





72 Summary Although the EFSA study contains a lot of valuable information on the 
GA levels in Solanaceae, the study actually uses only a very limited 
amount of this information. For example, matrix interactions in the diet 
have not been discussed when determining the LOAEL value based on 
experiments with human volunteers. We further notice that most of 
industry information has not been used. This leads to potential 
underestimation of exposure and further limiting the value and basis of 

























Starch Europe noticed that the study is completely focused on the toxic 
effects of GA. The literature searches are based on the presumption 
that there are only toxic effects. Most probably this is EFSAs mandate, 
but it makes the study scientifically unbalanced. There is a wealth of 
information on the beneficial effects of GA, especially the 
anticarcinogenic effects of GA. For your information we have included a 
recent review article on this (Att 1). Also, such GA positive publications 
When considering a LOAEL of 1 mg TGA/kg bw 
identified from human observations as a 
reference point for risk assessment, preference 
was given to the outcome of studies and 
reports, in which -solanine and -chaconine 
were administered or consumed as part of a 
potato meal (see Table 20 of the Opinion), 
taking matrix effects into account and mimicking 
or representing real exposure conditions at best.  
 
As was indicated in Section 3.2.1 of the Opinion 
the occurrence data submitted by Starch Europe 
could not be used for the exposure assessment 
due to uncertainty in the data (e.g. it was not 
known if the occurrence data referred to dry or 
wet weight and it was not always known if the 
samples referred to feed or food for human 
consumption). Other occurrence data indicated 
to be available to EFSA was not submitted 
following the requirements of the EFSA 
Guidance on Standard Samples Description for 
Food and Feed, and thus could not be used for 
the exposure assessment. This was indicated in 
the Section ‘Documentation provided to EFSA’. 
The additional data submitted by EUPPA during 
the public consultation (see also response to 
comment 53) could not be used for the dietary 
exposure assessment in this risk assessment. 
However, occurrence data submitted in SSD 
format will be stored and considered for future 
risk assessments. 
 
The mandate received focuses on the risk 
assessment related to the presence of GAs in 
feed and food (See Section Background and 
TORs) and not on the evaluation of the possible 
beneficial effects of GAs. Note however, that 
anti-inflammatory effects of GAs and the 
beneficial effects on blood lipids are discussed in  
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contain valuable scientific knowledge on GA that should not be 
excluded from the EFSA exposure assessment. 
 
Food use of potato and potato products has a long history of safe use, 
irrespective of how they are grown, stored, sold and used. Today’s 
levels of GA appear to be safe. To the best of our knowledge 
consuming potatoes and potato products has never led to assignable 
cause of health issues in the European population. And if so we would 
expect such information discussed in the study. Only in very exceptional 
and limited cases or under experimental dietary conditions detrimental 
effects of consuming GA were reported.  
 
 
On the basis of this EFSA study we do not see a strong case for 
lowering the GA level beyond what is today already the standard in 
many members states. Especially, as mentioned above, it is already 
reported that there could be important beneficial health effects of GA.    
Sections 3.1.2.4 and 3.1.2.9 of the Opinion.   
 
 
About a century ago, fatalities were reported 
from consumption of green or unripe potatoes. 
No fatalities have been reported since in Europe.  
The risk assessment presented here is referring 
to a LOAEL of 1 mg/kg bw as a reference point 
which is derived from more recent data. Taking 
a MOE 10 is considered to be protective for 
adverse effects which may be induced by 
potato-GAs.  
 
From the risk assessment perspective, the 
beneficial health effects of GAs are outside the 
remit of this mandate. Questions related to 
maximum levels in food are risk management 
actions and are outside the remit of EFSA.  
73 1.3.1. 
Chemistry 
Line 448 GAs are relatively stable to heat and alkaline conditions. This 













Line 450 and 451. Please quantify poorly soluble and soluble. Also, 
what is the solubility in fat/oil; what is the Pow; This related to effects 
of fat in the diet on bioavailability and the potential effect of GA in 
water solution administered in intake assessment with volunteers 
As pure substances and in potato matrix, potato 
GAs have been found stable at temperatures up 
to 150°C (Nie et al., 2018; Takagi et al., 1990). 
Frying typically occurs at higher temperatures, 
while during boiling of potatoes losses of GAs 
may occur due to extraction by the boiling water 
(Nie et al., 2018). The heat stability of GAs as 
pure standards to temperatures up to 150°C has 
now been added to the text in Section 1.3.1. 
Note that the stability of GAs (-solanine and -
chaconine) is also discussed in Section 3.2.4.1.2 
of the Opinion under ‘Other processing 
methods’. 
 
The text has now been revised. The aglycones 
are not soluble in water, while the intact GAs are 
slightly soluble. The solubility of -solanine in 
water has been added to the text.  
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74 1.3.3.1. 
Potatoes 
Line 608 Potato breeding programs have for quite a long time used 
many primitive forms of cultivated potatoes and their wild relatives as a 
valuable source of genetic variation. Add reference e.g. 
https://www.wur.nl/en/Research-Results/Statutory-research-
tasks/Centre-for-Genetic-Resources-the-Netherlands-1/CGN-potato-
collection.htm   
 
Line 616 and 617 However, in general, the tuber concentrations of 
these other GAs will be low. Please quantify. Reference? How does this 




Line 626 Potatoes can be classified into four types, namely for ‘table 
use’, ‘industrial food processing use(s)’, ‘starch production’, and ‘other 
purposes’, including colourful potatoes (Mori et al., 2015). Potato use 
can be classified… Potato varieties are bred that have characteristics 
that are more suitable for one or more of use classes. 
 
Line 632 Table 1 Kozukue and Mizuno (1989) (reference (6) in the 
table) write: In the pith, however, a small amount of a-chaconine and 
only a trace amount of a-solanine were detected. Therefore in the 
table, "pith; not detected; (6)" is not correct. 
Some relevant publications in this area have 
now been added to the text as references (Distl 





In tubers the content of other GAs is less than 
5%; references have been added, i.e. Milner et 
al., 2011; Friedman et al., 1997. The toxicity of 
(other) GAs was discussed in Section 3.1.2 of 
the Opinion. 
 






This has now been corrected. Kozukue and 
Mizuno (1989) report concentrations ranging 
from non-detectable to 0.1 mg/kg in the pith. 













Line 828 Does EFSA has sufficient data on glycoalkaloid content in 
potatoes in EU member states or other countries where there is no TGA 













Line 871 Methodology; Studies that report beneficial non-toxic effects 
are systematically ignored by this search method, while these studies 
can provide valuable information on absorption, dose response etc 
The occurrence data used for the estimation of 
the exposure was submitted by three countries, 
i.e. Germany, the Netherlands and Sweden. The 
CONTAM Panel notes that there are no sufficient 
data available to draw any conclusion whether in 
countries with no national legislation or 
recommendation on the maximum limits of GAs 
in potato and potato products, the GA levels are 
higher than in countries with such standards in 
place, and vice versa.  
 
The link to the US-Food and Drug Administration 
Poisonous Plant Database has been updated.  
 
 





Line 1042 Use of RPC Consumption database to convert FoodEx codes 
to amount of RPC 
Line 1065-1071 Reduction factors. Also Line 4077-4080 Reduction 
factors ……and these were applied to the occurrence data. 
Line 4073 occurrence data in the RPC was used. It is not clear from 
the text how the reduction factors are applied. Based on Table 38 (line 
3612) it is concluded that reduction factors for frying are determined 
based on dry weight to dry weight. While in the exposure assessment 
are converted to amounts RPC as fresh weight. And line 4077-4080 
indicate that the reduction factors are applied on the RPC. This would 
be fine if dry matter of both food and RPC are similar and correct 
reverse yield factor is applied. However in case of potato crisps there is 
a large difference between dry matter in crisps and in RPC and the 
reversed yield factor (slicing and frying) is unclear. Please, provide an 
example for Crisps showing how the conversion to reduction factor is 
applied by EFSA. 
The RPC model uses conversion factors (reverse 
yield factors) and ingredient percentages of 
composite food products that can be found in 
Annex A of EFSA (2019). The reverse yield 
factor takes into account the change in moisture 
content due to the effect of the processing step 
(i.e. frying and slicing). 
 
The reduction in the TGA content due to the 
processing steps (e.g. processing factors for 
peeling and for deep frying) are estimated from 
the available literature as described in section 
3.2.3.1.2 of the Opinion. These processing 
factors are not affected by differences in 
moisture content. 
 
The conversion that is applied to potato crisps is 
as follows: crisps are considered to consist of 
65% potatoes (the rest is fat and salt, see 
Annex A.4). The reverse yield factor for deep 
frying combined with slicing is 1.92 (see Annex 
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A.5 of EFSA, 2019). Example: 50 g of crisps 
consumed correspond to 62.4 g of main-crop 
potatoes (50 g x 65/100) x 1.92 = 62.4 g). 
 
For a raw potato that has a TGA concentration 
of 100 mg/kg and assuming the potatoes to be 
peeled before drying, the TGA exposure due to 
the consumed crisps is calculated as follows: 
62.4 g of main-crop potatoes × (100 mg/kg TGA 
× processing factor for frying extracted from a 
normal distribution within range of 0.1 and 0.8) 
× processing factor for peeling extracted from a 







Line 2036 To conclude, there is experimental evidence for the 
formation of undigestible complexes between alpha-tomatine and 
cholesterol in the gastrointestinal tract of rodents, which may enhance 
fecal elimination of sterols. How might formation of complexes affect 
bioavailability or absorption of GAs. Also in light of the studies with 
human volunteers that received experimental "diets' with no fat present 
(Mensinga et al 2005, Hellenäs 1992; ). Is perhaps the way of 
experimental dosing over estimating the absorption of GAs by humans 
from normal fat containing diets. 
In experimental models the formation of 
undigestible complexes with cholesterol has 
been studied and described for a-tomatine and 
not for potato GAs. For potato GAs there are no 
experimental or volunteer studies showing 
interference of cholesterol with the absorption of 
potato GAs in the gastrointestinal tract.   
78 3.1.3.1. GAs 
from S. 
tuberosum 
Line 2058 and 2059 At doses > 1 mg/kg bw, potato GAs are 
considered to be toxic to humans. Literature reference? 
Reference to JECFA (1993) has now been 
included to support this statement in the 
Opinion. Further specific relevant references are 
given in Table 20 of the Opinion.  
79 3.1.6.1. GAs 
from edible 
parts of S. 
tuberosum 
Line 2953 Based on the available information, the CONTAM Panel 
considered the LOAEL of 1 mg potato TGA/kg bw per day based on 
human data from case reports, outbreaks and studies in volunteers, as 
the reference point for acute exposure to potato TGAs via food. The 
establishment of the 1 mg/kg bw/d as LOAEL is a very important step 
and deserves or even requires a more comprehensive explanation on 
how it was established. This ' based on human data from case reports, 
outbreaks and studies in volunteers' is far to generic and lacks 
reasoning 
Cross-reference has been made to Section 
3.1.3.1 and Table 20, providing a detailed 
description of the studies to support the 
identification of the LOAEL if 1 mg/kg bw per 
day.  













Line 3004 The major contributor of data on GA in terms of number of 
results was Germany (73% of the results) while the Netherlands and 
Sweden contributed with 21% and 6%, respectively. 94% of the data 
comes from countries having a limit of GA 100 mg/kg in potatoes. What 
is the chance that this underestimates the true GA content of potatoes 


















Line 3085-3087 The European Starch Industry Association submitted 
data to EFSA concerning 1,728 samples including samples on dietary 
fibre and potato proteins, pulp, juice and starch and on potatoes used 
for starch production (Table 29). Due to uncertainty on the occurrence 
data reported (e.g. it was not known if the occurrence data referred to 
dry or wet weight and it was not always known if the samples referred 
to feed or food for human consumption) and the difficulties expressed 
by the data provider in retrieving this information, these data were not 
included in the exposure assessment. We note that data submitted by 
European Starch Industry Association, but also data submitted by 
European Snacks Association (Line 4137) and European Potato 
Processors’ Association (Line 4143) are not used in the exposure 
assessment. Could this lead to potential underestimation of GA 
presence in potato products? 
The CONTAM Panel acknowledges that the 
dataset submitted to EFSA is limited as only data 
from three Member States are available. 
Nevertheless, the available data may present a 
good impression of the TGA content present in 
potatoes for human consumption in the EU 
considering the following: (i) The three Member 
States indicated are responsible for about 30% 
of the potato production in the EU (FAOSTAT 
data 2018). (ii) Part of the data submitted by 
the Member States comes from retail potatoes 
that were produced in other Member States. The 
TGA content in these samples was not statically 
different from that in the home-grown potatoes.  
It should also be noted that the probabilistic 
approach in the current risk assessment takes a 
wide range of variables into account (differences 
in consumption, in TGA content and in 
processing factors). The uncertainty related to 
the actual TGA content is therefore considered 
to be covered by the confidence intervals 
calculated in the exposure assessment. 
 
As it was indicated in Section 2.2.1 of the 
Opinion and under ‘Documentation provided to 
EFSA’, the occurrence data indicated to be 
available by the European Snacks Association 
(ESA) and by the European Potato Processor’s 
Association (EUPPA), was not submitted in a 
timely manner or following the requirements of 
the EFSA Guidance on Standard Samples 
Description for Food and Feed, and thus could 
not be used for the exposure assessment (see 
response to Comment 53). The limited 
occurrence data submitted to EFSA to perform 
the exposure assessment (from three countries 
only) introduces uncertainty on the 
representativeness of the overall statistics. 
Possible differences in GA levels in potatoes, due 








Chapter Comment(a) EFSA response 
to the use of different cultivars, location, 
different growing conditions, and year to year 
variability, across European countries may result 
in over- or underestimation of exposure for 
certain food consumption surveys (see Section 
3.5.1 of the Opinion). 
 
The occurrence data submitted by EUPPA during 
the Public Consultation could not be analysed 
and validated by EFSA. From a preliminary 
comparison, the levels in potato samples seem 
to be in the same range compared to the data 
included in the current assessment. However, a 
detailed analysis would be required for a robust 
comparison. 












data in feed 
Line 3052 and 3052 The mean UB occurrence in the RPC main-crop 
potatoes was 52.0 mg/kg with a P95 of 117.0 mg/kg. The minimum 
and maximum reported concentrations were 1.1 mg/kg and 550.0 
mg/kg, respectively. 
Line 3309 Table 32. Summary results of surveys… This table indicate 
higher average TGA levels in consumption potatoes. How is this taken 
into account in the assessment, what considerations have been made 
based on the data in table 32 regarding the GA value used for RPC in 







Line 3313 Table 33 total glycoalkloids in laboratory processed 
commercial potato products. Have the GA levels that follow from the 
conversion from FoodEX foods into RPC and vise versa been compared 
to the values found in the lab research? Where is verified that the GA 
levels e.g. assigned to French fries, crips, flakes etc have been assessed 
well? 
The CONTAM Panel acknowledges that 
occurrence data presented in the literature may 
differ from the data submitted to EFSA. The 
main purpose of the data presented in this table 
(as well as other tables in this Opinion 
describing survey data) is to provide background 
information on the GA levels in raw and 
processed products reported in other studies. 
The data as such is not used in the exposure 
assessment by EFSA. Only data submitted to 
EFSA in the prescribed format can be used for 
the assessment (after necessary validation steps 
have been conducted, as described in Sections 
2.2.2 and 3.2.1 of the Opinion).  
 
The approach taken did not characterise the 
occurrence in the individual original foods. The 
range of occurrence values assigned to eating 
events concerning French fries, crisps, etc, is 
likely very wide as the occurrence values were 
randomly chosen from the full occurrence 
dataset related to main-crop potatoes. The same 
applies to the processing factors that were 
randomly chosen from a wide range (for frying 
and deep frying between 0.1 and 0.8, and for 
peeling between 0.25 and 0.75). 
82 3.2.4.1. GAs 
from S. 
tuberosum 
Line 3631 table 40. Please be aware that Takagi et al. (2009) write in 
the title of the original article that in fried potatoes the amount of GA is 
expressed on Raw weight. This would mean that the GA values are 
erroneous expressed as 'mg/ kg fried potato as is' as indicated in the 
heading of table 40. 
A footnote has now been added to clarify that 
the results are expressed as raw weight, 
corrected for water loss during frying, as was 
indicated by the authors. 








Chapter Comment(a) EFSA response 
83 4.2.1. Food Line 4077-4080 Reduction factors ……and these were applied to the 
occurrence data. Line 4073 occurrence data in the RPC was used. 
 
It is not clear from the text how the reduction factors are applied. 
Based on Table 38 (line 3612) it is concluded that reduction factors for 
frying are determined based on dry weight to dry weight. While in the 
exposure assessment are converted to amounts RPC as fresh weight. 
And line 4077-4080 indicate that the reduction factors are applied on 
the RPC. This would be fine if dry matter of both food and RPC are 
similar and correct reverse yield factor is applied. However in case of 
potato crisps there is a large difference between dry matter in crisps 
and in RPC and the reversed yield factor (slicing and frying) is unclear. 
Please, provide an example for Crisps showing how the conversion to 
reduction factor is applied by EFSA 
See reply to Comment 77. 
84 Other 
comments  
In general; where is the information that GA intake does lead to 
assignable cause of health problems in the potato consuming 
population. Cases that have been reported are rare and exceptional. 
 
 
In general; The report summarizes lots of scientific studies and includes 
data collection etc but these are not considered in important steps in 
the study, nor discussed in relation to the chosen basis assumptions 
(LOAEL, GA in RPC, reduction factors) for the exposure assessment. 
The CONTAM Panel has described the evidence 
available in Section 3.1.3 and also in Section 
3.3.2 on exposure assessments reported in the 
literature.   
 
The data used to inform the risk assessment is 
described in Section 2. The considerations and 
how these data has been used to conclude on 
the risk for human and animal health are 
described in Section 3 and sub-sections therein.  
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85  NUTRIONAL RESEARCH “NONLYONE” writer Doct Antonella Garzelli 
italian researcher POSITION MANAGEMENT AT FAIR TRADE LONDON 
FIELD HEALTH AND FOOD 
 
INDEX 
1 Instruction how to read this document 
2 Question number 
3 Risk 
4 Label 




9 Tables Figures 
 
1 HOW TO READ THIS DOCUMENT 
 
With the aim to be an active member of the authority food that refer to 
be productive and symplify with knowledge and research and practise 
on the market guarantee the safety and legal conditions  
 
From the number 3 the evidence of the risk that requires label the 
product one is extract from the risk assessment one is extract from 
partner company of authority food trusted sources in order to support 
the edible line of the field 
 
SIMPLIFY this is my value the word means make something simpler or 
easier to do or understand refer to mathematical concept that you 
should to consider in the procedural organization like this 
 
READ THE DOCUMENT ATTACHMENT refer to Question number: EFSA-
Q-2016-00811  
EFSA has disregarded the comment due to the 
fact that the comment sent was not in the scope 
of the consultation, since considerations on 
labelling of food products are outside the remit 
of the risk assessment of contaminants.  
 
The affiliation of Ms Garzelli mentioned in the 
EUSurvey as "EFSA Staff” is not correct. She is 






86 -  1. The report is asked for by the European Commission aiming to add a 
scientific opinion to review the overall evidence of epidemics (medical) 
such that the consequences for human health can be firmly identified. 
The greatest concerns (for national authorities and the WHO) are all 
the cancers, diabetes, obesity and the most frequent six non 
The methodology for the identification of studies 
to inform the risk assessment is detailed in 
Section 2.1 and Appendix B. Besides the 
literature search outsourced, complementary 
searches were performed to ensure that the 
















Annex D of this 
Technical 
report.] 
communicable diseases. The European Union is notably the most 
afflicted. For example, the file for the ANSES of France (Agence 
National de Sécurité et Santé) is Nutrivigilance 2016-006 (concerning 
the potato and it’s biocontamination). 
 
The Draft Assessment of the Mandate explains that it contains not one 
phrase about non communicable diseases because the methodologies 
for examining the epidemics (including in Oncology) omit the specific 
toxin (glycoalkaloid) or lack a useful technique. The good sense of 
your report is noticed.  
 
2. The reading list (delivered by Prague). Most of the list reveals that 
the necessary work has not yet been done, therefore one can not yet 
draw a conclusion. That deduction and the contents of the Draft are 
almost identical to those of Kuiper-Goodman and Nawrot of Health 
Canada (Bureau of Chemical Safety) of 1990. The principle difference is 
that Goodman and Nawrot put up front the imperative for a Mandate to 
do that work instead of reading. The “very great effort” specified 
remains to be done (thirty years later). 
 
It is encouraging to see the sense of the EFSA Draft. Readers may 
perceive that the 200 pages about rare intoxications are interesting (in 
biochemistry), however what’s to notice (and take very seriously) – are 
the 500 pages missing. What’s to be resolved is that which the Draft 
omits. Rather than testing the perception of The Commission (will they 
notice), one deduces that the Mandate is not yet able to be satisfied. 
That is an ordinary objective observation which signals that a Mandate 
is required to do some work. ITT observes (and contributes ) that more 
than half of the notes “No evidence found” are because “No reading 
material presented”. Of those reasons, two thirds are deficiencies in the 
Reading List, while one third are because the necessary work remains 
to be done. 
 
Taking into account that Professor More succeeded in installing a 
program of education in epidemiology (and human health) within the 
EFSA and that certain members of the CONTAM panel understand very 
well the significance of mixtures (in exposure terms), keeping this 
Mandate open (and not yet finished) were logical and acceptable. The 
subject of non communicable diseases is else than negligible and 
saturated with medical observations that nutrition is the most 
probable cause (due to the largest number of indicators). 
studies available on GAs in several areas (e.g. 
toxicokinetics, toxicity in experimental animals, 
etc) relevant to the remit of the mandate were 
retrieved. The CONTAM Panel finds this 
methodology appropriate for the identification of 
studies to inform on the risk for animal and 
human health related to the presence on 
glycoalkaloids in feed and food, in particular 
potatoes and potato-derived products.  
 
 
Besides the literature search outsourced, 
complementary searches were performed to 
ensure that the studies available on GAs in the 
areas relevant to the remit of the mandate were 
retrieved. The CONTAM Panel identified several 
knowledge gaps and there is a need to improve 
the risk assessment for humans and to reduce 
the uncertainties. The Panel has formulated a 
list of recommendations to address these needs 
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3. Administrative points. It’s unstated why the list from Prague omitted 
the research and conclusions of the Harvard Medical School 
(Gestational Type 1 Diabetes) which established a unique cause 
(potato). That figured even in newspapers in France (for example Le 
Figaro, written by Anne Prigent). This is already known to the public. 
While the Chan Medical School of Public Health considered only the 
carbohydrate (at first), much is to be learnt from the fact that potatoes 








It’s unstated why the list missed the Inflammatory Bowel Disease 
investigation identifying Potato glycoalkaloids (2002, Patel B, Schutte R, 
Sporns P et Al). 
 
 
4. Fish. The chapter on effects on fish shows that the reading list from 
Prague lacked the conclusion of the vast expertise of Norway. Taking 
into account the needs for protein (carnivore fish), Norway hoped to 
pass the protein of potato on a very large scale. Only 5% of added 
potato protein caused a serious incident, limited by a fast reaction by 
the Security organisation. The scientific team heading the enquiry 
conclude that the biocontamination of glycoalkaloids is responsable. A 
potential environmental catastrophe (for the fjords, within the cages 
and due to effluent) was avoided. One recalls that a single batch can 
take up to four years to evolve. 
 
VKM Vitenskapskomiteen for Mattrygghet (Norwegian Scientific 
Committee for Food Safety) Norway already publish: “No estimate can 
be suggested for the maximum level of alkaloids in fish diets due to 
lack of relevant scientific information. It can however, be stated that 
the potato alkaloids are very toxic and should not be present in feed.” 
The effects at the incidence (paralysis) were modified to “severe 
appetite loss” and the total loss of reproduction modified to “rainbox 
trout embryos exhibit a toxic response to chaconine,  solasidine, repin 
and solanine” (Crawford, Kocan 1993). Toxic response means the 
 
The CONTAM Panel discussed the available 
epidemiological studies relevant for a possible 
association between repeated intake of GAs, e.g. 
by the consumption of potatoes, and health 
risks, e.g. congenital abnormalities or cancer 
(see Section 3.1.3.1.3 of the Opinion). However, 
due to missing information on the GA levels in 
the potatoes or GA intake, the Panel concludes 
that the designs and outcomes of these studies 
do not allow concluding on any causal 
relationship between the repeated intake of 
potato GAs and human health risks and that 
they therefore are not considered informative for 
the risk assessment of GAs in food.  
 
The study by Patel et al. (2002) was not missed 
and it was cited in the Opinion in Section 3.1.5.1 
to inform on membrane effects of GAs and 
implications for the gastrointestinal tract.  
 
Reference to the Opinion of the Panel on Animal 
Feed of the Norwegian Scientific Committee for 
Food Safety (2009) and references therein has 
now been made in Sections 3.3.3 and 3.1.4.5 of 
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glycolakaloids kill them. Therefore the biocontamination levels are 
specified as 0% and 0% (2009). ISBN 978-82-8082-299-4 
(05.02.2009). Also available as “Criteria for Safe Use of Plant 
Ingredients in Diets for Aquacultured Fish”. 
 
Numerous nations follow the EFSA activity. Tanzania has the intention 
to increase fish farming in the vast lake (for a greater food supply to 
the nation) and finds itself surrounded by potato suppliers (more 
usually for exportation) and close promotion by Finland and Belgium. 
They are less likely to provoke a colossal accident with their project, 
being (it seems) better informed. 
 
The Draft reveals that the list of Prague is incomplete and that the 
EFSA read without initiating communication with authorities already 
competent in fish farming. 
 
5. The readers may draw their own conclusions. It is considered best to 
note the request (placed by the Direction of EFSA Parma) to Brussels 
for a change of priorities, that which this subject of biocontam merits 
(noted as “sensitive”). The punctual, expert and justified request (from 
Parma in 2017) was refused. Brussels can no longer pretend that it 
wasn’t warned to pay attention. The quality of this Draft Opinion for 




6. Cancer. While the Draft Opinion suggests that existing techniques 
are inadequate for assessing potato consumption and resulting cancer, 
it were usual in a report of this type to explain why, show why and 
demonstrate it with the reference approach implied by the Panel as 
better and available. That’s a normal requirement. 
 
Example 1: Lene A Asli, Olsen, Braaten, Lund and Skele report in 
2017 (in the Journal of Nutrition and Cancer Volume 69). “Results 
showed that high potato consumption was associated with a 
higher risk of CRC (hazard ratio [HR]: 1.32, 95% confidence 
interval [CI]: 1.10, 1.60 for ≥3 potatoes per day versus 0–7 
potatoes per week). The same association was found for rectal 
cancer (HR: 1.68, 95% CI: 1.19, 2.36), and same tendencies 
were found for colon cancer (HR: 1.20, 95% CI: 0.96, 1.50). 

















EFSA and the CONTAM Panel received from the 
European Commission the request for a scientific 
opinion on the risks for animal and human 
health related to the presence of glycoalkaloids 
in feed and food. In the course of time, EFSA 
made two requests for extension of deadlines 
which were accepted by the EC. All 
correspondence is publicly available at the EFSA 
website under Register of questions.   
 
See reply to point 3 above. The relationship 
between the intake of potatoes and risks of 
cancer in the gastrointestinal tract has been 
investigated as mentioned in Section 3.1.3.1.3 of 
the Opinion. A causal relationship between diets 
with the consumption of large quantities of 
potatoes and increased risks of cancers of the 
brain, breast, endometrium, lung and thyroid 
was not found (Hopkins, 1995; Tice, 1998). 
Moreover, the CONTAM Panel noted that the 
design and outcome of existing studies did not 
allow concluding on the causal relationship 
between intake of potato GAs and cancer risks.    
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significant associations were found with BMI <25 kg/m2 for CRC 
(HR: 1.48, 95% CI: 1.15, 1.89) and rectal cancer (HR: 1.95, 95% 
CI: 1.25, 3.06).” 
Example 2: Potato consumption is associated with total and 
cause-specific mortality: a population based cohort study and 
pooling of prospective studies with 98,569 participants. 2020 Feb 
11;16(2):260-272. doi: 10.5114/aoms.2020.92890. eCollection 
2020. “3433 deaths occurred during the mean follow-up of 6.4 
years. In multivariate adjusted models, total (42%), CVD (65%), 
cerebrovascular (26%) and cancer (52%) mortality risk was 
greater in individuals with higher potato consumption than those 
with the lowest intake (p < 0.001 for all comparisons). These 
findings should be taken into consideration for public health 
strategies, establishing the position for potatoes in the food 
pyramid”.  
 
These examples are clearer than most and the second puts forward the 
facts to the Food Safety Authorities who debate whether a nutrition will 
receive a waiver (derogation) or product recall. 
 
7. Nonetheless one hopes that the Draft can put forward (more evident, 
with more emphasis) the topic of it’s limitations rather than remaining 
silent to see if the readers will notice it for themselves. This is normal in 
all objective disciplines and every profession. 
 
Our Institute wishes you a fruitful continuation (with this Mandate still 





















The limitations and uncertainties in the risk 
assessment are discussed in Section 3.5 and the 
Panel made a number of recommendations in 
order to reduce those uncertainties and improve 
the risk assessment.  
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87 Abstract Line 18 “no evidence of health problems. . . . .has been identified” is 
rather “the reading list used (concentrating on glycoalkaloid research) 
omitted most literature concerning health problems for humans 
(epidemiology compared to potato consumption), specifically Non 
Communicable Diseases, therefore little or no evidence was presented”. 
 
Line 79 “metabolic profiles in experimental animals could not be 
characterised”. Line 84 “No further information available on 
metabolism and excretion of potato GAs in humans”. Line 86 “no 
toxicokinetic data in animals and humans”. Line 89 “Reliable data on 
other potato GAs or tomato and aubergine GAs and their aglycones are 
missing”. Line 104 “Developmental studies have been performed 
mainly in hamsters treated with GAs and their aglycones for only one 
day or for a short, very restricted time period during gestation”. Line 
109 “No NOAEL or LOAEL could be identified”. Line 116 “From the 
limited number of studies available, there was no evidence for 
genotoxicity”. That is very unusual use of english. “no evidence” meant 
“no literature presented because no work done”. 






The CONTAM Panel based the risk assessment 
on the available published scientific literature in 
the open domain and reported the available 
information to inform the risk assessment.  
88 Summary Line 119 “No long-term chronic toxicity/carcinogencity study for . . . . 
.GAs or for the respective aglycones could be identified”. Unfortunately 
untrue. Prague visited many such studies (registered by the Berlin 
based researchgate tracker). The Panel may, perhaps, find it acceptable 
to state that “Of the long-term chronic toxicity/carcinogencity studies 
found by literature search, Prague forwarded none to the EFSA working 
group”. Of course it’s up to the Contam Panel to explain why not. The 
major reason for the Mandate is, of course, the Food Safety alarm 
notice Nutrivigilance 2016-006 of the ANSES of France due to a 
carcinogencity study (2015) and the second study (2016) forwarded to 
all nations, the WHO, the FAO and the EFSA was published (also as a 
food safety alarm) on precisely the 22 november 2016. ITT asked for 
that date (the night before the EFSA mandate was received 23  
november) to illustrate to the Panel members that ITT is thoroughly 
integrated within the European Commission and internationally. An 
engineer is asked to present it, to guarantee impartiality (no prior 
responsibility for the existing toxicity thresholds nor recent choices in 
Europe to modify them).  
 
Line 127 “Results from limited volunteer studies suggest possible 
difference in the human population with respect to the individual 
susceptibility towards adverse effects”. ITT (Walker) offers that nearly 
The CONTAM Panel did not identify any long-
term chronic toxicity study either by the 
outsourced literature search or additional 
searches and updates of the scientific literature 















Endogenous fatty acids and fatty acids in food 
may exert effects on many physiological and 
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all GA modes of action depend on binding EPA/DHA and Branched 
Chain Fatty Acids. Free EPA/DHA is liberated during illness or present in 
other nutrition. ITT (Walker) presents only the facts (no models) of all 
world population results (double-blind) as the victims demonstrating 
three major points. The Fatty Acids amplify the toxicity because the 
Solanaceae plant plans it’s minimalist GA toxin to economise it’s own 
effort and resources. Other plants do this too. No study has done a 
human biocontam mixtox (GA/fatty acid) controlled experiment 
anywhere and all animal experiments require perfect health. That’s why 
a world epidemiology analysis was offered, to find the circumstances in 
what 5 billion participants had already done (in 2012) without 
researcher intervention and with very variable background health states 
(triple blind measure). As usual for clinical trials also (of  
pharmaceutics), the human experience and measures surpass and 
supercede initial speculative animal experiments. It’s quite alright for 
the EFSA to mention this fact as Medically trained who read, know it 
already.  
 
Secondly it’s presented (ITT, 2016, using only incidence rates results) 
that the GA toxin has an action when it is the lesser of the two 
ingredients, the intended toxin victim providing the greater 
fatty acid partner. The harm, the epidemics and the evidence illustrate 
the complex effect of ratios where (mostly) the mode of action by GA is 
worst when it is the lesser in the chemical reaction (the EPA/DHA very 
high). The point of the conclusions is that toxicity thresholds are 
useless when the reaction and mode of action is so sophisticated with 
the GA mode acting like a gas leak (to explode in toxicokinetic rate 
rather than trickle the aglycone. Researchers have to know the toxic 
ration to be able to give their models something to look for). Aflatoxin 
(in comparison) synthesises it’s own Fatty Acid to prepare a complete 
toxin before the epoxide phase. While this is difficult news for 
the Commission and the WHO, it’s more directly of help if the EFSA 
mentions that it does have copies and did read them. The Contam 
Panel is requested to refrain from expressions typical for first time 
readers about breakthroughs renaming them as “assertions” or “theory” 
(the actual word used in the very recent examination of Cancer/Potato 
done in Iran). The group in Iran do state that their use of the model 
was only “quantitative” which means neither mixtox, nor taking into 
account the chemical fact (new to them) nor any effort at toxicokinetic 
examination. The “old” method produced no correlations at all and that 
is to be expected. The EFSA Contam Panel view that those methods are 
pathological processes. However, this aspect 

















Endogenous fatty acids and fatty acids in food 
may exert effects on many physiological and 
pathological processes. However, this aspect 
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insufficient for this subject is noted and true. Many may not like the 
facts presented and what that implies, because their prior education 
was without knowledge of basic chemistry that often it takes two 
molecules to cause histological damage. It’s unexpected yet has to be 
learnt.  
 
Thirdly. Unlike the Aflatoxin method, the GA intoxication creates the 
Cell Cancer Initiation metabolite C17H34N3O7S (molar mass 424.211) 
later, within the victim. Humans can and do usually convert the 
metabolites of the biocontaminated meal into useful sugar molecules 
without difficulty, which is very impressive. However, when that 
defence is compromised (due to ill health such as HPV virus) the 
initiation occurs and there’s another cancer victim. 
 
Some Quantum Chemistry was applied to double-check the ITT 
presentations and the Contam Panel may need help from Physical 
Chemistry expertise. It’s unlikely that Cox’s models (1972) will ever 
produce consistent identification of GA effects without guidance about 
the need to offer the model the key ratios of Fatty Acid/GA with their 
amplifications. Haphazard and conflicting reports are to be expected 
until that guidance is given.  
 
Line 130 “adverse effects of GA may be due to the ability to complex 
with membrane 3beta hydroxy sterols”. ITT offers that (from a 
toxicologists point of view) the complete mode can best be measured 
along the hexane toxicity pathway. However, not only is a deliberate 
mixtox GA/EPA/DHA experiment dangerous but now unethical (because 
evidence of harm and it’s mode has already been presented by ITT, 
including 5 billion measures of incidences and survivals, for a whole 
year). Researching any single cancer type incidence rates of 20 in 
10000 during one year in humans is categorically unfeasible using 
human volunteers in a three day toxicokinetics scenario (Netherlands) 
or an animal laboratory setting using ten animals for two days. 
 
It’s regrettable; however the EFSA fortunately suggests that in 2021 it 
will have acquired some qualifications in epidemiology and may already 
be prepared to do a mixtox analysis. A biocontam mixtox review may 
be the first (of many) yet a very good idea. 
 
Line 155. “The experimental data available for repeated dose toxicity 







From the literature, no evidence for genotoxic 
potential and thus tumour initiating potential of 
potato GAs could be identified (see Section 
3.1.2.7 of the Opinion). A putative GA 
metabolite with a molecular mass of 424.211 
and a molecular formula of C17H34N3O7S could 
not be retrieved from the scientific literature and 









The CONTAM Panel is not aware of the ‘hexane 
toxicity pathway’ in the context of GAs. 
Endogenous fatty acids and fatty acids in food 
may exert effects on many physiological and 
pathological processes. However, this aspect 












The CONTAM Panel considered all reliable 
studies to assess the risks for human health 
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potato GAs”. The unusual feature of the report is comparing to line 149 
which commences “Assuming the main symptoms . . . .”. It’s 
unexpected to see the term “assume” (which appears twice) anywhere 
in a report of this significance to medical science. “The Panel 
considered that the possible interindividual variability in toxicodynamics 
is more relevant that the interindividual variability in toxicokinetics”. 
That’s a hypothesis and insufficient to justify an MOE, LOAEL or NOAEL 
about any toxin. The amplification of toxicity (by rates) depending on 
what else the victim eats and his or her actual health at the moment of 
ingestion can be scientifically investigated. Work needs to be done to 
ascertain the true character of the GA capability and dispersion into 
tissues. Were the EFSA Panel to be firm about that normal technical 
observation (on something as important as this subject), the 
Commission were better placed to organise the Working Groups who 
will do work. 
 
Line 156. “no evidence of health problems associated with repeated or 
long-term intake of GA via potatoes has been identified” is very out of 
date. Reports from 2015, 2016, 2017 and 2019 are uploaded. The 
report AOMS is specific about the health problem. Death. “These 
findings should be taken into consideration for public health strategies, 
establishing the position for potatoes in the food pyramid”. That does, 
of course, mean that the researchers decline to recommend a waiver or 
derogation themselves, yet recognise that it’s up to the EFSA and 
others to choose (probably best a recall). China is the furthest 
advanced in this matter (2019), already researching centrifuge 
processing (yet failing so far to remove all GA to zero%) and consulting 
with industry (Tereos) to learn if using potato for ethanol production 
will be viable instead (2000 installations already in China). China FSA is 
neither nor more less inclined to discretion about it’s Working Group 
meetings; the difference is that China does new work rather than only 
read. 
 
New item relating to Line 156. ITT has asked for a brochure for the 
public to give them the original method for knowing about the risk of 
potato toxic tubers - now. The method dates from circa 1200 AD, needs 
no apparatus, is without danger, can be done by any level of education 
and works. To distribute it in 2020, ITT (Walker) will use printed 
material, so members of the Panel or the Public need only to read (in 
that particular case) and participate for a four minute exercise. A 
following dietary exposure to GAs. Scientific data 
on the impact of dietary habits and health status 














The mandate from the EC to EFSA asked for a 
scientific opinion on the risks for animal and 
human health related to the presence of GAs in 
feed and food, in particular in potato and 
potato-derived products. Risks and benefits of 
potato consumption not directly related to GAs 
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printed preview is available for the CONTAM Panel only on request, in 
French or English or both. The short brochure in french has a further 
and longer demonstration of ITT skill (small book only in French) which 
covers ITT activity in depth, across four or five disciplines. The public 
will be able to learn about ITT competence directly, without distortions 
of opinions by biased or anxious administrators. A completely fresh 
look, without reproach. Nothing adversarial. ITT is aware of 
confrontations with interested parties, those with conflicts of interest 
and criticisms of the EFSA. ITT offers, instead something kind, useful, 
pertinent and precise, to the CONTAM Panel members too. 
 
Lines 160 to 206 and section 2.5 (Lines 1046+) methodology. 
The summary implies that the CONTAM Panel infer an overview 
instruction to search for and find LOAEL, NOAEL and MOE or to explain 
where the existing values originated. This is the usual EFSA business. 
Yet the Mandate (on this occasion) asks for much more, is completely 
open – to something new. The Prague team (Biochemistry) also 
misunderstood the Mandate as seeking a ratification of an existing 
norm, therefore provided information (or lack of) about that with very 
little attention to human exposure analyses and none at all to the Food 
Safety Alarm (of France, provided by ITT 2016), therefore missing 
entirely it’s content and the implications. While the Commission may 
note the procedure followed by the Mandate Working Group explains 
how simplistic (quantitative only) deductions are made, the Commission 
is aware of the presentation of other results and reports implying 
something new has to be learnt. It’s quite alright if the summary 
remains as it is so that the Commission learns if the EFSA can do it 
(only by reading). The Mandate omitted to guide that the breakthrough 
concerns the alarm that GA is relatively inert until bound with 
EPA/DHA/Branched Chain Fatty Acids. 
 
Integrated Laboratory Systems (Zeiger, Tice) remark already in 1998 “ 
The relationship between the consumption of potatoes and cancer risk 
has been investigated but remains undetermined. Casecontrol 
studies reporting increased risks of digestive tract tumors (e.g., colon, 
esophagus, rectal, and stomach cancer) associated with high levels of 
potato consumption are matched by an equal number of studies 
reporting a decreased risk for these same cancers.” ITT has 













GAs may interact with sterols in the cell 
membranes. There are no peer-reviewed data in 
the scientific literature indicating that 
interactions of GAs with fatty acids may increase 
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The RPC Consumption Database may be sufficient to submit to a mixtox 
analysis now. ITT notes (2015), with caution, that disease epidemiology 
for Multiple Sclerosis indicates the mixtox saturates and only nations 
outside the European consumption habits/diets can provide the contrast 
that all models need to function. In that particular example, even with 
Epidemiological expertise, the RPC Consumption Database is known to 
be insufficient. Linear and non-linear basic algorithms applied 
in the 2019 Tehran (Iran) cancer investigation were unable to detect 
the multiple ratio effect either. The subject requires technique and work 




Line 142 might benefit from Line 829+. Citing other authorities (and 
BfR’s choice to halve the GA content in 2018) is else than a suitable 
justification technique. The Mandate implies that putting those 
improvisations (quantitative only) into question is necessary and 
something new is required from the CONTAM Panel to explain why. For 
example Line 823. “Since case reports in humans indicate a lethal dose 
of 3–6 mg/kg bw, whereas the LD 50 for mice and rats is at least 300-
fold higher, BfR pointed to the considerable higher sensitivity of 
humans compared to rodents.” This observation were usually found at 
that top of the report, near or in Line 142. Then readers may 
continue while considering the questions why and when are humans 
vulnerable and which illnesses may result, else than death, before 
death. That’s why the Mandate is completely open, not requiring 
nor requesting a NOEL. Notably, BfR gave regulations about quantities 
of potatoes per day, given to Industry providers, without any publicity 
for medical personnel nor the public. 
 
ITT is aware how Prague chose search criteria, why certain literature is 
claimed as excluded (yet gathered and read with caution) and that the 
EFSA or other authorities may choose to enquire or not as they deem 
fit. The ITT reports were Food Safety Alarms, required and requested 
as a Public Duty (by law also). These are most often prepared and filed 
by Food suppliers recently aware of an accident within 24 hours. 
Unsuitable for an annual scientific research journal. The ITT reports 
were distributed very quickly due to the deductions (from epidemiology 
already done, the gold standard for decisions) showing a pandemic 
situation (across very many non communicable diseases). China, 
Norway, Iran, Denmark, Poland, Greece, Great Britain understood and 
The exposure assessments performed by EFSA 
focus on the European population. Since 
available occurrence data did not cover all the 
food categories containing potatoes in the 
Consumption Database, the CONTAM Panel 
decided that the best approach for the exposure 
assessment would be to use the occurrence 
values in the RPC (main-crop potatoes and new 
potatoes) and the RPC Consumption Database. 
This is mentioned in Section 2.5 of the Opinion. 
The mandate of EFSA includes the exposure 
assessment to GAs by the European population. 
  
The line number indicated refers to Section 1.3.5 
on Legislation and other standards. This section 
provides a summary of existing legislation, 
standards or recommendations on the maximum 
limits of GAs in food in European countries or 
beyond. EFSA has performed its own risk 
assessment as reported in Section 3 according 










Information on the literature search and 
selection for relevance made to inform the risk 
assessment can be found in Section 2.1 of the 
Opinion. The CONTAM Panel has applied an 
MOE approach to assess the health risks and has 
also made a number of recommendations to 
improve the assessment and reduce the 
uncertainties. The establishment of maximum 
levels of GAs in food or related measures are 
outside the remit of EFSA.  
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passed to action on most of the topics. One former EFSA employee 
(now toxicology advisor to the HSA of the United Kingdom) 
unfortunately replied that “People just need to remember to cut off the 
green bits”. It is hoped that the CONTAM Panel take into account that 
ITT is well aware of the administrative obligations, interpretations, 
statements, derogations (for substances or supplies considered 
“important”), all the laws and regulations and how they were 
established, without need of authoritative instructions nor orders about 
it. Many nations understand this – of immediate concern due to new 
evidence and demonstrated. The EFSA is invited to name the analyses 
“novel methodology” if that helps give the topic a category acceptable 








89 2.3.2. Feed 
consumption 
data  
Line 1023. Fish. Limited success is inaccurate. All embryons are killed 
outright. Norway VKM has already concluded the issue (what 
happened). Therefore the biocontamination levels are specified as 0% 
and 0% ISBN 978-82-8082-299-4 (05.02.2009). The reason to mention 
this (including the partial paralysis of the fish) is because fish tissue is 
with a very high EPA density. ITT knows why VKM chose to reduce the 
warning to “fish may lose appetite” when the facts are far more 
significant. VKM realised this and mention only that there’s “insufficient 
information” to explore why, without placing a work order. Evidently, 
others may then continue to suggest that there’s “no evidence” when 
it’s because there’s “no work done”. 
Reference to the Opinion of the Panel on Animal 
Feed of the Norwegian Scientific Committee for 
Food Safety published in 2009 has now been 
made in Section 3.3.3 and Section 3.1.4.5 of the 
Opinion and references included therein in the 





Line 862. Evidence from 1924 and 1996 is suggested as authoritative, 
because the OECD cite it. Not what the Mandate asks for. 
 
Section 1.3.5 on Legislation and other standards 
provides a summary of existing legislation, 
standards or recommendations on the maximum 
limits of GAs in food in European countries or 
beyond. EFSA has performed its own risk 
assessment as reported in Section 3 according 
to the mandate received from the European 
Commission.  













Line 873. Extensive literature search. The project was then limited (by 
Prague) from “extensive” to “narrowed”, correctly declaring the search 
methods used. The additional complementary searches are stated as 
only “Web of Science, PubMed and Scopus”. However, the ITT Food 
Safety Alarm reports (2015, 2016, Walker) were found, downloaded 
and read. It’s understood that the Panel may feel that original, new 
mixtox analysis already done by someone else is very surprising and 
very difficult news. It is hoped that the Panel may specify (to the 
Commission) what was read, why simple presentation is striking and 
useful and what work orders and education are necessary to 
evaluate (in the scientific context). 
Information on the literature search and 
selection for relevance made to inform the risk 
assessment can be found in Section 2.1 of the 
Opinion.   
92 3.1.2.2.1. GAs 
and aglycones 
from edible 
parts of S. 
tuberosum 
Line 1462. “Potatoes were admixed as powder at high concentrations 
to the diet (of mice) presumably causing dietary imbalances of macro- 
and micronutrients”. “Increased absolute and relative weights of 
pancreas were observed at the highest TGA dose of 23.2 mg/kg bw per 
day. The CONTAM Panel agrees with the assumption of the authors 
that the effects on the pancreas may be due to presence of trypsin 
inhibitor activity in the potato powder and not caused by GAs. 
Consequently, no NOAEL was derived for this study”. ITT is unsurprised 
to see the word “assumption”. The Mandate suggests the CONTAM 
Panel assume nothing, to find out also whether they will report 
absolutely objectively. ITT hopes to alert the Contam Panel to reflect 
again on the Friedman report in question which (on careful reading) 
contains a very significant observation. 
 
Furthermore, ITT is aware that the Panel had a useful disagreement, 
discussing this point, which might serve as a more accurate and 





Animal experiments are else than trusted by Pathologists and 
Pharmaceutical science due to the vast numbers of differences, the fact 
that the animals are in perfect health at start, denied alternative 
selfselected liquids or nutritions and effects on humans are always 
examined to replace (completely) animal testing. What animal 
experiments can do is reveal histological damage to vital organs. 
The animal experiments published, including the 
studies by Friedman et al. applied doses being 
lethal for humans. Therefore, these studies were 
considered inappropriate to draw conclusions for 
the health risks of humans exposed to 









Following scientific discussions on possible 
approaches for the risk assessment, the 
CONTAM Panel was unanimous in the approach 
taken and endorsed the draft Opinion for public 
consultation and adopted the Opinion without 
disagreements among its members.    
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That is often their only value. It occurred in these experiments 
therefore to be emphasised rather than dismissed. If anything is to be 
learnt from animal testing – this is it. 
 
The useful fact is that the researchers (1992) did no further work (yet) 
to determine which substance caused the damage. 
 
In addition, readers of the report with experience in Oncology may 
need some overview help. Trypsin inhibitor is found to be associated 
with adverse prognosis for cancer victims and regularly used to prepare 
life expectancy information for the patient and their family (possible 
recovery or imminent death). Whether in tissue and/or in serum, the 
usual indication is poor survival, particularly associated with liver 
metastasis. ITT will present another report (in 2020) with the full 
database (as for 2016 yet much larger). To preview, the most recent 
analysis learns that the liver is the major detoxification organ for potato 
aglycones yet the pancreas suffers a dysfunction causing the Diabetes 
epidemics for nations (the worst are else than European). The liver can 
be relieved of the load, yet only be dumping toxins into the  
bloodstream for later expulsion by the lungs and treatment in the 
kidneys (European diets/fluids do that). That full circulation, however 
brief, enables the cycloalkane metabolite to initiate cancer in nearly 
every organ with the worst possible results for the largest organ (the 
skin), known as Melanoma. In this way, medical science notices 
the switch (disease exchange) from Diabetes to Cancer without yet 
being able to explain it. 
 
As developing nations adopt western customs and diet behaviour (only 
rarely or even only once), the expulsion from the liver is always more 
probable and cancer epidemics soar. The World Health Organisation 
appeals (desperately) for Western Science to react and investigate 
absolutely any and every possible avenue of evidence without relent. 
The ITT report of 2020 will enable the EFSA to participate in the reality 
of the imminent catastrophies rather than read about what was or was 
not done. ITT can warn the Panel, to help prepare, respectfully, that 
one of it’s options is to keep the Mandate open, as not yet resolved due 
to work not done. 
 
Line 1489. ITT contributes that variable proportions of potato powder 
and spiked GA will cross several ratios of the EPA/GA mixtox. Therefore 








The CONTAM Panel is not aware of a 
‘cycloalkane metabolite’ in the context of GAs 
toxicity. From the literature, no evidence for 
genotoxic potential and thus tumour initiating 
potential of potato GAs could be identified (see 


























See replies to Comment 89. 
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toxicity. This is, of course, basic chemistry. Citing more quantitative 
studies risks assuming there’s nothing to be done and may cause 
avoidance of the very simple evaluation possible.  
 
Line 1522. “The Tusino study authors speculated that alterations were 
rather due to trypsin inhibitor activity than the GA content in the diet 
(2013). Consequently, no NOAEL or LOAEL could be derived”. This 
illustrates again the focus on NOAEL. The Mandate is larger in scope 
(deliberately so). The useful fact is that, due to speculation, it remains 
unkown if the GA or the trypsin inhibitor was responsible (or both). ITT 
request that the CONTAM Panel pulls out and forward the facts only 





The Panel agrees that the effects of GAs and 
trypsin inhibitors need to be kept apart, which 
was followed in the present Opinion. 
(a): Comments are shown as received from the commenters.  
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Abbreviations 
ARfD Acute reference dose 
bw Body weight 
CONTAM Panel Panel on Contaminants in the Food Chain  
dw Dry weight 
EU European Union 
EUPPA European Potato Processors' Association 
FAO Food and Agricultural Organization 
FDA Food and Drug Administration 
FID Flame ionization detector 
fw Fresh weight 
GAs Glycoalkaloids 
GC Gas chromatography 
HPLC High pressure liquid chromatography 
LC Liquid chromatography 
LOAEL Lowest-observed-adverse-effect level 
LOEL Lowest-observed-effect level 
LOD Limit of detection 
LOQ Limit of quantification 
MALDI Matrix assisted laser desorption/ionization 
MOE Margin of exposure 
MS Mass spectrometry 
NOEL No-observed-effect level 
NOAEL No-observed-adverse-effect level 
NPD Nitrogen phosphorous detector 
RPC Raw primary commodities 
TGA Total glycoalkaloids 
TOF Time of flight 
UB Upper bound 
UF Uncertainty factor 
UV Ultraviolet 
WHO World Health Organization 
ww Wet weight 
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Appendix A – Explanatory note to Public Consultation  
EFSA's Panel on Contaminants in the Food Chain (CONTAM) has launched an open consultation on the 
draft scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids 
in feed and food, in particular in potatoes and potato-derived products. This document presents an 
estimation of the acute human dietary exposure to glycoalkaloids, and an assessment of the human 
health risks related to this dietary exposure. No risk assessment was possible for any of the farm animal 
species. 
Interested parties are invited to submit written comments by 15 April 2020. 
Please use the electronic template 
provided: https://ec.europa.eu/eusurvey/runner/Public_Consultation_GAs to submit comments and 
refer to the line and page numbers. To submit additional data to support your comments or files, there 
is an upload function available in the tool (for a maximum size of 1Mb file). 
Otherwise you can also contact specific unit’s functional mailbox: biocontam@efsa.europa.eu 
Please note that comments will not be considered if they: 
 are submitted after the closing date of the consultation 
 are presented in any form other than what is provided for in the instructions and template 
 are not related to the contents of the document 
 contain complaints against institutions, personal accusations, irrelevant or offensive statements 
or material 
 are related to policy or risk management aspects, which are out of the scope of EFSA's activity. 
EFSA will assess all comments which are submitted in line with the criteria above. The comments will 
be further considered by the relevant EFSA Panel and taken into consideration if found to be relevant. 
Due to time constraints, EFSA cannot use additional occurrence data submitted during the public 
consultation for the dietary exposure assessment in this risk assessment. However, occurrence data 
submitted in SSD format will be stored and used for future risk assessments. 
Copyright-cleared contributions 
Persons or organizations participating in a Public Consultation of EFSA are responsible for ensuring that 
they hold all the rights necessary for their submissions and consequent publication by EFSA. Comments 
should inter alia be copyright cleared by taking into account EFSA’s transparency policy and practice to 
publish all submissions. In case the submission reproduces third-party content in the form of charts, 
graphs or images, the required prior permissions of the right holder(s) should have been obtained by 
the PC respondent 
Publication of contributions 
Contributions will be published (as part of an EFSA report published together with the final opinion) and 
may be re-used by EFSA in a different context. It should be noted that contributions submitted by 
individuals in a personal capacity will be published as such, indicating the author’s first and family name, 
unless a substantial justification for protection is provided by the respondent. Contributions submitted 
on behalf of an organization are also made publicly available and attributed to the organization in 
question. 
Submit comments (deadline: 15 April 2020) 
Published: 27 February 2020 
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Annex A – Contribution submitted by EUPPA 
The following xls files were submitted by EUPPA together with his contribution to the public consultation:  
 GA consultation _ occurrence reporting UK and FR 
 GAs SSD2 simplified – BELGAPOM 
 GAs SSD2 simplified – BPOGK (003) 
Due to time constraints, EFSA cannot use additional occurrence data submitted during the 
public consultation for the dietary exposure assessment in this risk assessment. However, 




Annex B – Contribution submitted by STARCH EU 
The following file was submitted by STARCH EU together with his contribution to the public consultation:  
 2020.04.15__Starch_Europecomment_-_draft_EFSa_opniion_on_GA 
This file is available on the EFSA Knowledge Junction community on Zenodo at: 
http://doi.org/10.5281/zenodo.3952756 
 Friedman, 2015, glycoalkaloids, eggplants, potatoes, tomatoes, anticarcinogenic 
mechamisms  
 
This file corresponds to the following citation: Friedman M, 2015. Chemistry and 
Anticarcinogenic Mechanisms of Glycoalkaloids Produced by Eggplants, Potatoes, and 





Annex C – Contribution submitted by Antonella Garzelli 
The following file was submitted by Antonella Garzelli together with his contribution to the public 
consultation:  
 DOCANTONELLA_GARZELLI_GA_Question_numberEFSAQ201600811 




Annex D – Contribution submitted by Matthew Walker 
The following files were submitted via email by Matthew Walker to the public consultation:  
 ITT to EFSA – Public Consultation GA in food and feed 
This file is available on the EFSA Knowledge Junction Community on Zenodo at: 
http://doi.org/10.5281/zenodo.3952772 
 ITT CancerCauseDeclarationforFAOWHO. 
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This file is available on the EFSA Knowledge Junction Community on Zenodo at: 
http://doi.org/10.5281/zenodo.3952772 
 ITT CancerInitiationmetaboliteofpotato20042016.  
This file is available on the EFSA Knowledge Junction Community on Zenodo at: 
http://doi.org/10.5281/zenodo.3952772 
 ITT Food Safety Alert – Nutrivigilance ANSES 2016-006. 
This file is available on the EFSA Knowledge Junction Community on Zenodo at: 
http://doi.org/10.5281/zenodo.3952772 
 AOMS Mortality (2019) London, Lodz, Thessalonika_Art_39831-10.  
This file corresponds to the following citation: Mazidi M, Katsiki N, Mikhailidis DP, Pella D, 
Banach M, on behalf of the Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) 
Group, 2020. Potato consumption is associated with total and cause-specific mortality: a 
population-based cohort study and pooling of prospective studies with 98,569 participants. 
Archives of Medical Science, 16, 260–272. https://doi.org/10.5114/aoms.2020.92890  
 GA Antidote 10886_2005_Article_BF01012098. 
This file corresponds to the following citation: Johns T, 1986. Detoxification function of 
geophagy and domestication of the potato. Journal of Chemical Ecology, 12, 635-646. 
 Harvard MS Gestational Diabetes bjm.h6898.full.  
 
This file corresponds to the following citation: Bao W, Tobias DK, Hu FB, Chavarro JE and 
Zhang C, 2016. Pre-pregnancy potato consumption and risk of gestational diabetes 
mellitus: prospective cohort study. BMJ 2016;352:h6898. DOI: 10.1136/bmj.h6898  
 Norway potatoconsumptionandriskofcolorectalcancer 
This file corresponds to the following citation: Asli A, Olsen A, Braaten T, Lund E and 
Skeie G, 2017. Potato Consumption and Risk of Colorectal Cancer in the Norwegian 
Women and Cancer Cohort.  Nutrition and Cancer, 69, 564-572. DOI: 
10.1080/01635581.2017.1295086. 
 Renwick 1974 Spina Bifida. Storage and half life toxins. 
This file corresponds to the following citation: Renwick J, Possamai AM and Munday MR, 
1974. Potatoes and spina bifida. In: Persaud TVN (eds) Problems of Birth Defects. Springer, 
Dordrecht. DOI: https://doi.org/10.1007/978-94-011-6621-8_42  
 VKM 07 604. 
This file corresponds to the following citation: Norwegian Scientific Committee for Food 
Safety, 2009. Opinion of the Panel on Animal Feed of the Norwegian Scientific Committee 
for Food Safety. Criteria for safe use of plant ingredients in diets for aquacultured fish. 
Available at: https://vkm.no/download/18.2994e95b15cc5450716356b2/1498419374011/
1232b28f3b.pdf   
  
 
